<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">FpZRkwTwB9f6B67PRQfpYyJ</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2021000701127</article-id>
      <article-id pub-id-type="publisher-id">abc.20190397</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20190397</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Influ&#234;ncia do Consumo de Suco de Laranja (Citrus Sinensis) na Remodela&#231;&#227;o Card&#237;aca de Ratos Submetidos a Infarto do Mioc&#225;rdio</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-8825-6980</contrib-id>
          <name>
            <surname>Oliveira</surname>
            <given-names>Bruna C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-1159-5030</contrib-id>
          <name>
            <surname>Santos</surname>
            <given-names>Priscila P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueiredo</surname>
            <given-names>Amanda M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rafacho</surname>
            <given-names>Bruna P. M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ishikawa</surname>
            <given-names>Larissa</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-0607-8189</contrib-id>
          <name>
            <surname>Zanati</surname>
            <given-names>Silm&#233;ia G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Ana A. H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azevedo</surname>
            <given-names>Paula S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-2875-9532</contrib-id>
          <name>
            <surname>Polegato</surname>
            <given-names>Bertha F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-9831-8820</contrib-id>
          <name>
            <surname>Zornoff</surname>
            <given-names>Leonardo A. M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-5980-4367</contrib-id>
          <name>
            <surname>Minicucci</surname>
            <given-names>Marcos F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-4412-1990</contrib-id>
          <name>
            <surname>Paiva</surname>
            <given-names>Sergio A. R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label> 1 </label>
        <institution content-type="orgname">Universidade Estadual Paulista J&#250;lio de Mesquita Filho</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina de Botucatu</institution>
        <addr-line>
          <named-content content-type="city">Botucatu</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original"> Universidade Estadual Paulista J&#250;lio de Mesquita Filho Campus de Botucatu - Faculdade de Medicina de Botucatu , Botucatu , SP - Brasil </institution>
      </aff>
      <aff id="aff2">
        <label> 2 </label>
        <institution content-type="orgname">Instituto de Bioci&#234;ncias</institution>
        <addr-line>
          <named-content content-type="city">Botucatu</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original"> Instituto de Bioci&#234;ncias Campus de Botucatu (UNESP), Botucatu , SP - Brasil </institution>
      </aff>
      <aff id="aff3">
        <label> 3 </label>
        <institution content-type="orgname">Food Research Center FoRC</institution>
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original"> Food Research Center FoRC , S&#227;o Paulo , SP - Brasil </institution>
      </aff>
      <author-notes>
        <corresp id="c01">Correspond&#234;ncia: Sergio A. R. Paiva &#8226; Faculdade de Medicina de Botucatu - Rubi&#227;o J&#250;nior, CEP 18618-970, Botucatu, SP - Brasil <email>E-mail:sergio.paiva@unesp.br</email> </corresp>
        <fn fn-type="con">
          <p>Contribui&#231;&#227;o dos autores</p>
          <p>Concep&#231;&#227;o e desenho da pesquisa: Oliveira BC, Santos PP, Rafacho BPM, Azevedo PS, Polegato BF, Zornoff LAM, Minicucc MFI, Paiva SAR; Obten&#231;&#227;o de dados: Oliveira BC, Figueiredo AM, Ishikawa L, Zanati SG, Fernandes AAH; An&#225;lise e interpreta&#231;&#227;o dos dados: Oliveira BC, Santos PP, Figueiredo AM, Rafacho BPM, Ishikawa L, Zanati SG, Fernandes AAH, Azevedo PS, Polegato BF, Zornoff LAM, Minicucc MFI, Paiva SAR; An&#225;lise estat&#237;stica e Reda&#231;&#227;o do manuscrito: Oliveira BC, Paiva SAR; Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante: Santos PP, Azevedo PS, Polegato BF, Zornoff LAM, Minicucc MFI, Paiva SAR.</p>
        </fn>
        <fn fn-type="conflict">
          <p>Potenciais conflitos de interesse</p>
          <p>N&#227;o h&#225; conflito com o presente artigo</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>14</day>
        <month>06</month>
        <year>2021</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <month>06</month>
        <year>2021</year>
      </pub-date>
      <volume>116</volume>
      <issue>6</issue>
      <fpage>1127</fpage>
      <lpage>1136</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>07</month>
          <year>2019</year>
        </date>
        <date date-type="rev-recd">
          <day>29</day>
          <month>03</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>06</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Resumo</title>
        <sec>
          <title>Fundamento</title>
          <p>O suco de laranja (SL) &#233; rico em polifen&#243;is com propriedades anti-inflamat&#243;rias e antioxidantes. Ap&#243;s o infarto do mioc&#225;rdio (IM), mudan&#231;as complexas ocorrem na estrutura e na fun&#231;&#227;o card&#237;acas, processo conhecido como remodela&#231;&#227;o card&#237;aca (RC). O estresse oxidativo e a inflama&#231;&#227;o podem modular esse processo. Nossa hip&#243;tese foi a de que o consumo de SL atenua a RC ap&#243;s o IM.</p>
        </sec>
        <sec>
          <title>Objetivos</title>
          <p>Avaliar a influ&#234;ncia do SL sobre a RC ap&#243;s IM pela an&#225;lise de vari&#225;veis funcionais, morfol&#243;gicas, de estresse oxidativo, de infla&#231;&#227;o, e de metabolismo energ&#233;tico.</p>
        </sec>
        <sec>
          <title>M&#233;todos</title>
          <p>Um total de 242 ratos machos pesando entre 200 e 250g foram submetidos a um procedimento cir&#250;rgico (liga&#231;&#227;o da art&#233;ria coron&#225;ria ou cirurgia simulada). Sete dia ap&#243;s a cirurgia, os animais sobreviventes foram divididos para um dos quatro grupos: 1) SM, animais sham que receberam &#225;gua e maltodextrina (n= 20); 2) SSL, animais sham que receberam SL (n= 20); 3) IM, animais infartados que receberam &#225;gua e maltodextrina (n= 40); e 4) ISL, animais infartados que receberam SL (n = 40). A an&#225;lise estat&#237;stica foi realizada pelo teste de ANOVA com dois fatores com o teste de Holm-Sidak. Os resultados foram apresentados em m&#233;dia &#177; desvio padr&#227;o, e o n&#237;vel de signific&#226;ncia adotado foi de 5%.</p>
        </sec>
        <sec>
          <title>Resultados</title>
          <p>Tr&#234;s meses depois, o IM levou &#224; hipertrofia do ventr&#237;culo esquerdo (VE), com disfun&#231;&#227;o sist&#243;lica e diast&#243;lica, e aumento nos mediadores inflamat&#243;rios e de estresse oxidativo. Os animais que consumiram SL apresentaram menor atividade da glutationa peroxidase e maior express&#227;o da heme-oxigenase-1 (HO-1).</p>
        </sec>
        <sec>
          <title>Conclus&#227;o</title>
          <p>O SL atenuou a RC, e a HO-1 pode exercer um importante papel nesse processo.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="pt">
        <kwd>Infarto do Mioc&#225;rdio</kwd>
        <kwd>Sucos de Frutas</kwd>
        <kwd>Citrus Sinensis (laranja)</kwd>
        <kwd>Polifen&#243;is</kwd>
        <kwd>Remodela&#231;&#227;o Ventricular</kwd>
        <kwd>Anti-Inflamat&#243;rios</kwd>
        <kwd>Antioxidantes</kwd>
        <kwd>Ratos</kwd>
      </kwd-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="6"/>
        <equation-count count="0"/>
        <ref-count count="52"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introdu&#231;&#227;o</title>
      <p>O nome <italic>polifen&#243;is</italic> , ou <italic>compostos fen&#243;licos</italic> , refere-se a um grande grupo de mol&#233;culas encontradas em verduras, frutas, cereais, ch&#225;, caf&#233;, cacau, soja, e suco de fruta. <sup><xref ref-type="bibr" rid="B1">1</xref></sup> Esses compostos t&#234;m sido estudados devido ao seu potencial efeito biol&#243;gico na preven&#231;&#227;o e tratamento de diferentes doen&#231;as. <sup><xref ref-type="bibr" rid="B2">2</xref> , <xref ref-type="bibr" rid="B3">3</xref></sup></p>
      <p>Em revis&#227;o da literatura, Hyson mostrou que o suco da fruta, definido como suco puro ou 100% suco, reteve a maioria dos nutrientes e fitoqu&#237;micos da fruta &#237;ntegra e, portanto, pode ser importante no benef&#237;cio e prote&#231;&#227;o da sa&#250;de humana. <sup><xref ref-type="bibr" rid="B4">4</xref></sup> O suco de laranja (SL) &#233; fonte de compostos fen&#243;licos na forma de diferentes flavonoides. O principal flavonoide de interesse &#233; a hesperidina e sua forma hidrolisada, a hesperetina. <sup><xref ref-type="bibr" rid="B5">5</xref></sup> O interesse na pesquisa sobre as propriedades do SL aumentou devido &#224; sua a&#231;&#227;o anti-inflamat&#243;ria e antioxidante nas doen&#231;as cr&#244;nicas. <sup><xref ref-type="bibr" rid="B6">6</xref></sup></p>
      <p>Por exemplo, na les&#227;o mioc&#225;rdica, suplementos de antioxidantes podem ter efeito ben&#233;fico na remodela&#231;&#227;o card&#237;aca (RC). Em estudos usando modelo de infarto do mioc&#225;rdio (IM), compostos bioativos presentes no alecrim, tomate, e ch&#225; verde, e antioxidantes tais como &#225;cido asc&#243;rbico, quercetina, alfa-tocoferol, e vitamina A mostram efeito protetor contra a RC. <sup><xref ref-type="bibr" rid="B1">1</xref> , <xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B7">7</xref> - <xref ref-type="bibr" rid="B10">10</xref></sup></p>
      <p>A doen&#231;a card&#237;aca isqu&#234;mica, incluindo o IM, &#233; uma causa importante de insufici&#234;ncia card&#237;aca e morte em todo o mundo. Ap&#243;s o IM, mudan&#231;as complexas no ventr&#237;culo esquerdo (VE) podem causar altera&#231;&#245;es no tamanho, na massa, e na geometria do cora&#231;&#227;o, e na fun&#231;&#227;o card&#237;aca. <sup><xref ref-type="bibr" rid="B11">11</xref> , <xref ref-type="bibr" rid="B12">12</xref></sup> Tais mudan&#231;as s&#227;o definidas como RC e podem levar &#224; insufici&#234;ncia card&#237;aca e aumento na mortalidade. <sup><xref ref-type="bibr" rid="B13">13</xref></sup> Muitos fatores podem estar envolvidos na RC, incluindo estresse oxidativo, inflama&#231;&#227;o, fibrose, e apoptose. <sup><xref ref-type="bibr" rid="B14">14</xref> , <xref ref-type="bibr" rid="B15">15</xref></sup></p>
      <p>No IM, a isquemia inicia a gera&#231;&#227;o de esp&#233;cies reativas de oxig&#234;nio (EROS). As EROS danificam diretamente as membranas celulares, ativam a resposta inflamat&#243;ria, e levam &#224; morte celular. Elas tamb&#233;m podem atuar como sinais de transdu&#231;&#227;o, estimulando o fator nuclear kappa B (NF-&#954;B), o qual estimula a s&#237;ntese de citocinas pr&#243;-inflamat&#243;rias. <sup><xref ref-type="bibr" rid="B14">14</xref> - <xref ref-type="bibr" rid="B16">16</xref></sup> Al&#233;m disso, o sistema KEAP-1/Nrf2 (prote&#237;na 1 associada a ECH tipo Kelch/fator nuclear eritroide 2 relacionado ao fator 2) poderia ser ativado durante o estresse oxidativo celular, e exercer papel cr&#237;tico na homeostase redox. Esse &#233; um mecanismo universal que atua nos genes-alvo do Nrf2, conhecidos como elementos de resposta antioxidante. A glutationa peroxidase (GPx) e a heme-oxigenase-1 (HO-1) s&#227;o exemplos de prote&#237;nas reguladas por esse sistema. <sup><xref ref-type="bibr" rid="B17">17</xref></sup></p>
      <p>Estrat&#233;gias terap&#234;uticas para atenuar a RC ap&#243;s o IM t&#234;m sido muito estudadas. <sup><xref ref-type="bibr" rid="B18">18</xref> , <xref ref-type="bibr" rid="B19">19</xref></sup> Bloqueadores de aldosterona, inibidores da enzima conversora de angiotensina e betabloqueadores s&#227;o algumas dessas estrat&#233;gias. <sup><xref ref-type="bibr" rid="B20">20</xref></sup> Nesse contexto, os compostos bioativos de produtos naturais, com propriedades cardioprotetoras, tais como os flavonoides, podem ser importante adjuvante no tratamento de IM. Por outro lado, estudos mostram que um foco em padr&#245;es alimentares e diet&#233;ticos, e n&#227;o em nutrientes ou fitoqu&#237;micos individuais, &#233; melhor para a sa&#250;de cardiometab&#243;lica. <sup><xref ref-type="bibr" rid="B21">21</xref></sup> Assim, o objetivo deste estudo foi avaliar a influ&#234;ncia da ingest&#227;o de SL sobre a RC ap&#243;s IM.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materiais e m&#233;todos</title>
      <sec>
        <title>Protocolo experimental</title>
        <p>Todos os experimentos e procedimentos foram conduzidos de acordo com as diretrizes para o cuidado e o uso de animais em laborat&#243;rio dos Institutos Nacionais da Sa&#250;de (NIH), e aprovados pela Comiss&#227;o de &#201;tica no Uso de Animais da Faculdade de Medicina de Botucatu, UNESP, S&#227;o Paulo, Brasil (1126/2015). Foram utilizados 242 ratos Wistar machos, pesando 200 - 250 g. O IM foi induzido por liga&#231;&#227;o da art&#233;ria coron&#225;ria, como descrito previamente. <sup><xref ref-type="bibr" rid="B22">22</xref> , <xref ref-type="bibr" rid="B23">23</xref></sup></p>
        <p>Ap&#243;s a cirurgia, os animais foram colocados em caixas com seis animais cada. Sete dias depois, o primeiro estudo ecocardiogr&#225;fico foi realizado para avaliar a efic&#225;cia do procedimento cir&#250;rgico. <sup><xref ref-type="bibr" rid="B24">24</xref></sup> Com base nesse ecocardiograma, os animais foram alocados aleatoriamente em caixas com dois animais cada, para receberem SL ou uma solu&#231;&#227;o de maltodextrina (M). Os grupos foram: 1) SM, animais sham que receberam solu&#231;&#227;o de M (n=20); 2) SSL, animais sham que receberam SL (n=20); 3) IM, animais com infarto que receberam solu&#231;&#227;o de M; e 4) ISL, animais com infarto que receberam SL (n=40). O tamanho da amostra utilizada baseou-se em outros estudos realizados em nosso laborat&#243;rio. <sup><xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B8">8</xref> , <xref ref-type="bibr" rid="B25">25</xref></sup> O n&#250;mero de ratos no grupo infartado foi maior, uma vez que a mortalidade esperada para esses animais durante o per&#237;odo experimental &#233; de aproximadamente 50%. Al&#233;m disso, somente animais com &#225;rea infartada do VE maior que 30% foram inclu&#237;dos no estudo. <sup><xref ref-type="bibr" rid="B24">24</xref></sup></p>
        <p>O alimento era oferecido &#224; vontade ( <italic>ad libitum</italic> ). Os animais foram tratados durante tr&#234;s meses, e a mortalidade foi avaliada nesse per&#237;odo ( <xref ref-type="fig" rid="f01">Figura 1</xref> dos dados suplementares). Os ratos foram acondicionados em temperatura controlada (22 &#177; 2&#176;C), com um ciclo claro-escuro de 12 horas.</p>
        <p>
          <fig id="f01">
            <label>Figura 1</label>
            <caption>
              <title>&#8211; Express&#227;o de fator nuclear eritroide 2 relacionado ao fator 2 (Nrf2) e heme-oxigenase-1 (OH-1) em ratos sham e ratos infartados por Western blot. Gr&#225;fico de barras mostrando a express&#227;o de Nrf-2 e de HO-1 em cada grupo (A) express&#227;o do Nrf-2 e Western blot representativo; tamanho da amostra: 8 animais em cada grupo; (B) express&#227;o de HO-1 e Western blot representativo; tamanho da amostra: SM = 5; SSL = 6; IM = 5; ISL = 5; GAPDH gliceralde&#237;do -3-fosfato-desidrogenase; dados expressos em m&#233;dia &#177; DP. p(I): valor p entre animais infartados e n&#227;o infartados; p(SL): valor p entre animais que receberam maltodextrina e animais que receberam suco de laranja; p(IxSL): representa o valor de p quando houve intera&#231;&#227;o entre fatores relacionados a infarto e fatores relacionados ao consumo de suco de laranja</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-116-06-1127-90397-gf01.tif"/></fig>
        </p>
      </sec>
      <sec>
        <title>Liga&#231;&#227;o da art&#233;ria coron&#225;ria</title>
        <p>O IM foi induzido por liga&#231;&#227;o da art&#233;ria coron&#225;ria, conforme descrito previamente. <sup><xref ref-type="bibr" rid="B22">22</xref> , <xref ref-type="bibr" rid="B23">23</xref></sup> Em resumo, os ratos foram anestesiados com cetamina (70mg/Kg) e xilazina (1mg/Kg). Ap&#243;s toracotomia esquerda, o cora&#231;&#227;o foi retirado. O &#225;trio esquerdo foi retra&#237;do para facilitar a liga&#231;&#227;o da art&#233;ria coron&#225;ria esquerda, com fio mononylon 5.0 entre a sa&#237;da da art&#233;ria pulmonar e o &#225;trio esquerdo. O cora&#231;&#227;o foi recolocado no t&#243;rax, os pulm&#245;es inflados com press&#227;o positiva, seguido por fechamento da toracotomia. Tamb&#233;m se criou um grupo sham, em que os animais foram submetidos &#224; cirurgia sem oclus&#227;o coron&#225;ria. Ap&#243;s o efeito da anestesia, os ratos foram medicados oralmente com Metamizol s&#243;dico (30 mg / kg Dipirona&#174;, Biovet, Vargem Grande Paulista, S&#227;o Paulo, Brasil).</p>
      </sec>
      <sec>
        <title>Suco de laranja</title>
        <p>Os grupos SSL e ISL receberam suco de laranja em regime <italic>ad libitum</italic> . Os grupos controles (SM e IM) receberam uma solu&#231;&#227;o de &#225;gua e M na concentra&#231;&#227;o de 100g/L. A solu&#231;&#227;o de M foi dada aos animais controle para fornecer a mesma quantidade de carboidratos que o SL. O tratamento foi iniciado sete dias ap&#243;s a cirurgia. O SL e as solu&#231;&#245;es de M eram trocadas a cada 24 horas, e o consumo foi monitorado diariamente. A composi&#231;&#227;o nutricional do SL &#233; apresentada nos dados suplementares.</p>
      </sec>
      <sec>
        <title>Estudo ecocardiogr&#225;fico</title>
        <p>Ap&#243;s tr&#234;s meses, todos os ratos foram pesados e avaliados por ecocardiografia transtor&#225;cica. <sup><xref ref-type="bibr" rid="B26">26</xref> , <xref ref-type="bibr" rid="B27">27</xref></sup> Para o estudo ecocardiogr&#225;fico, os ratos foram anestesiados com inje&#231;&#227;o intramuscular de solu&#231;&#227;o de cetamina (50 mg/kg) e xilazina (1 mg/kg). As medidas foram feitas pelo mesmo observador, seguindo o m&#233;todo de &#250;ltima gera&#231;&#227;o recomendado pela Sociedade Americana de Ecocardiografia e a Associa&#231;&#227;o Europeia de Ecocardiografia. <sup><xref ref-type="bibr" rid="B28">28</xref></sup> O ecocardiograma foi realizado com o sistema General Electric Vivid S6 System (GE Medical Systems, Tirat Carmel, Israel), com sonda <italic>phased array</italic> de 5 a 12-MHz.</p>
        <p>Ap&#243;s o ecocardiograma, os animais foram eutanasiados com uma alta dose de pentobarbital, e os cora&#231;&#245;es foram removidos. O VE foi isolado e amostras foram retiradas e imediatamente congeladas e armazenadas a -80 <sup>o</sup> C. Um corte transversal do VE foi separado e fixado com formalina tamponada 10%, e embebidos em parafina para estudo histol&#243;gico.</p>
      </sec>
      <sec>
        <title>An&#225;lise morfom&#233;trica</title>
        <p>Cortes de cinco micr&#244;metros de espessura foram marcados com hematoxilina e eosina para c&#225;lculo do tamanho do infarto conforme descrito anteriormente. Todos os animais foram inclu&#237;dos na an&#225;lise morfom&#233;trica. Ap&#243;s o c&#225;lculo do tamanho do infarto, os animais infartados com menos de 30% do VE de &#225;rea infartada foram exclu&#237;dos das an&#225;lises. Todas as imagens foram coletadas com c&#226;mera de v&#237;deo acoplada ao microsc&#243;pio (Leica); as imagens foram analisadas usando o software Image-Pro Plus 3.0 (Media Cybernetics, Silver Spring, MD).</p>
      </sec>
      <sec>
        <title>Hidroper&#243;xido lip&#237;dico no tecido card&#237;aco, atividade de enzima antioxidante, e metabolismo energ&#233;tico card&#237;aco</title>
        <p>Amostras do VE (100mg) foram usadas para medidas de prote&#237;na total e hidroper&#243;xido lip&#237;dico (HL), e atividade das seguintes enzimas antioxidantes &#8211; GPx (E.C.1.11.1.9), super&#243;xido dismutase (SOD, E.C.1.15.1.1), e catalase (E.C.1.11.1.6). O metabolismo energ&#233;tico card&#237;aco foi avaliado pela atividade da 3-hidroxiacil coenzima-A desidrogenase (OHADH; E.C.1.1.1.35.), fosfofrutoquinase (PFK; E.C.2.7.1.11), lactato desidrogenase (LDH; E.C.1.1.1.27), piruvato desidrogenase (E.C.1.2.4.1), citrato sintase (CS; E.C.4.1.3.7.), e trifosfato de adenosina (ATP) sintase (EC 3.6.3.14). <sup><xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B9">9</xref></sup> Os testes de atividade enzim&#225;tica foram realizados a 25 <sup>o</sup> C com um leitor de microplaca (&#181;Quant-MQX 200-EONC com o software Gen5 2.0 conectado a um sistema de controle; Bio-Tec Instruments, VT, EUA). Todos os reagentes foram obtidos de Sigma (Sigma-Aldrich, St. Louis, MO, USA).</p>
      </sec>
      <sec>
        <title>Mediadores inflamat&#243;rios</title>
        <p>Concentra&#231;&#245;es de interferon-&#947; (IFN-&#947;) e interleucina-10 (IL-10) nas amostras do VE foram determinadas por ELISA seguindo-se as instru&#231;&#245;es do fabricante (R&amp;D Systems, Minneapolis, MN).</p>
      </sec>
      <sec>
        <title>Western blot</title>
        <p>O teste de Western blot foi realizado para analisar a express&#227;o proteica da GPx-1 (ab 22604 - Abcam Inc, Cambridge), HO-1 (ab13248 - Abcam Inc, Cambridge), NF-kB total e fosforilada (NF-kB- sc 8008 e sc 3302- Santa Cruz Biotechnology, Inc, Europa), e sirtu&#237;na-1 (Sirt-1- sc 15404-Santa Cruz Biotechnology, Inc, Europa), no extrato celular total. Para determinar o fator nuclear eritroide 2 (Nrf-2-sc 722-Santa Cruz Biotechnology Inc, Europe), amostras do VE foram extra&#237;das utilizando-se tamp&#227;o de extra&#231;&#227;o nuclear. <sup><xref ref-type="bibr" rid="B9">9</xref></sup> As amostras foram separadas em gel de poliacrilamida-dodecil sulfato de s&#243;dio (SDS-PAGE) a 10%, e as prote&#237;nas transferidas para uma membrana de nitrocelulose. A membrana foi bloqueada com leite em p&#243;s desnatado (5%) e em seguida incubada com anticorpo prim&#225;rio e anticorpo secund&#225;rio. Gliceralde&#237;do-3-fosfato desidrogenase (GAPDH) (sc 32233, Santa Cruz Biotechnology, Inc., Europa) foi usada para normaliza&#231;&#227;o das prote&#237;nas.</p>
      </sec>
      <sec>
        <title>An&#225;lise estat&#237;stica</title>
        <p>A normalidade dos dados foi verificada pelo teste de Kolmogorov&#8211;Smirnov. Os dados foram apresentados como m&#233;dia &#177; desvio padr&#227;o (DP). As vari&#225;veis com distribui&#231;&#227;o normal foram analisadas pelo teste de vari&#226;ncia com dois fatores, que fornece tr&#234;s valores p: 1) fator 1, presen&#231;a de IM (I); 2) fator 2, ingest&#227;o de SL (SL); e 3) intera&#231;&#227;o entres os fatores I e SL. Na an&#225;lise de vari&#226;ncia com dois fatores, assume-se a normalidade da distribui&#231;&#227;o dos dados. Se uma vari&#225;vel n&#227;o se ajusta &#224; distribui&#231;&#227;o normal, realiza-se transforma&#231;&#227;o dos dados. O teste t de Student n&#227;o pareado foi usado para an&#225;lise do ecocardiograma inicial. O teste do qui-quadrado foi usado para avaliar mortalidade, e o teste t de Student n&#227;o pareado foi usado para avaliar o tamanho do infarto nos animais infartados. As diferen&#231;as foram consideradas estatisticamente significativas se o valor de p fosse inferior a 0,05. As an&#225;lises estat&#237;sticas foram realizadas usando o programa SigmaPlot para Windows 12.0 (Systat Software Inc., San Jose, CA).</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Resultados</title>
      <p>O ecocardiograma inicial mostrou que os animais dos dois grupos de animais infartados n&#227;o apresentaram diferen&#231;as na &#225;rea sist&#243;lica e diast&#243;lica ou no tamanho do infarto ( <xref ref-type="table" rid="t1">Tabela 1</xref> do material suplementar).</p>
      <p>
        <table-wrap id="t1">
          <label>Tabela 1</label>
          <caption>
            <title>&#8211; Tamanho do infarto, ecocardiograma final, e an&#225;lise morfom&#233;trica</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Vari&#225;vel</th>
                <th>SM (n = 19)</th>
                <th>SSL (n = 20)</th>
                <th>IM (n = 9)</th>
                <th>ISL (n = 9)</th>
                <th>p (I)</th>
                <th>p (OJ)</th>
                <th>p (I&#215;OJ)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td>Peso corporal (g)</td>
                <td align="center">454&#177;47,9</td>
                <td align="center">480&#177;56,3</td>
                <td align="center">443&#177;66,6</td>
                <td align="center">462&#177;25,9</td>
                <td align="center">0,338</td>
                <td align="center">0,135</td>
                <td align="center">0,852</td>
              </tr>
              <tr>
                <td>FC (bpm)</td>
                <td align="center">290&#177;30,9</td>
                <td align="center">296&#177;34,9</td>
                <td align="center">268&#177;26,7</td>
                <td align="center">324&#177;30,0 <sup>aB</sup></td>
                <td align="center">0,756</td>
                <td align="center">0,001</td>
                <td align="center">0,009</td>
              </tr>
              <tr>
                <td>AE/Ao</td>
                <td align="center">1,32&#177;0,09</td>
                <td align="center">1,21&#177;0,09 <sup>b</sup></td>
                <td align="center">1,78&#177;0,21 <sup>A</sup></td>
                <td align="center">1,42&#177;0,18 <sup>Ba</sup></td>
                <td align="center">&lt;0,001</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,003</td>
              </tr>
              <tr>
                <td>DDVE/BW (mm/kg)</td>
                <td align="center">15,9&#177;1,31</td>
                <td align="center">15,0&#177;1,79</td>
                <td align="center">22,1&#177;2,70</td>
                <td align="center">20,2&#177;2,10</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,019</td>
                <td align="center">0,398</td>
              </tr>
              <tr>
                <td>DSVE/BW (mm/kg)</td>
                <td align="center">6,67&#177;0,87</td>
                <td align="center">6,02&#177;0,89</td>
                <td align="center">15,1&#177;2,70</td>
                <td align="center">12,8&#177;2,70</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,007</td>
                <td align="center">0,556</td>
              </tr>
              <tr>
                <td>IMVE (g/kg)</td>
                <td align="center">1,63&#177;0,22</td>
                <td align="center">1,56&#177;0,27</td>
                <td align="center">2,62&#177;0,60</td>
                <td align="center">2,36&#177;0,36</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,124</td>
                <td align="center">0,640</td>
              </tr>
              <tr>
                <td>FAC (%)</td>
                <td align="center">67,3&#177;8,28</td>
                <td align="center">67,4&#177;8,27</td>
                <td align="center">34,5&#177;8,28</td>
                <td align="center">36,6&#177;8,28</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,661</td>
                <td align="center">0,707</td>
              </tr>
              <tr>
                <td>Onda E (ms)</td>
                <td align="center">79,7&#177;11,3</td>
                <td align="center">81,4&#177;7,16</td>
                <td align="center">89,1&#177;10,8</td>
                <td align="center">80,7&#177;19,2</td>
                <td align="center">0,204</td>
                <td align="center">0,325</td>
                <td align="center">0,139</td>
              </tr>
              <tr>
                <td>Onda A (ms)</td>
                <td align="center">49,9&#177;8,28</td>
                <td align="center">52,6&#177;7,16</td>
                <td align="center">42,5&#177;16,5</td>
                <td align="center">62,7&#177;24,9 <sup>a</sup></td>
                <td align="center">0,730</td>
                <td align="center">0,004</td>
                <td align="center">0,025</td>
              </tr>
              <tr>
                <td>S&#180; m&#233;dia (cm/s)</td>
                <td align="center">5,78&#177;0,04</td>
                <td align="center">5,82&#177;0,31</td>
                <td align="center">4,60&#177;0,30</td>
                <td align="center">5,01&#177;0,3</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,028</td>
                <td align="center">0,078</td>
              </tr>
              <tr>
                <td>E&#180; m&#233;dia (cm/s)</td>
                <td align="center">5,62&#177;0,44</td>
                <td align="center">5,82&#177;0,45</td>
                <td align="center">4,23&#177;0,60</td>
                <td align="center">4,77&#177;0,60</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,054</td>
                <td align="center">0,357</td>
              </tr>
              <tr>
                <td>A&#180; m&#233;dia (cm/s)</td>
                <td align="center">3,67&#177;0,44</td>
                <td align="center">4,02&#177;0,45</td>
                <td align="center">4,54&#177;0,90</td>
                <td align="center">5,55&#177;1,20</td>
                <td align="center">0,058</td>
                <td align="center">0,058</td>
                <td align="center">0,28</td>
              </tr>
              <tr>
                <td>Raz&#227;o E/E&#180;</td>
                <td align="center">13,7&#177;3,49</td>
                <td align="center">14,1&#177;1,79</td>
                <td align="center">21,3&#177;3,30 <sup>A</sup></td>
                <td align="center">16,9&#177;2,40 <sup>Ba</sup></td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,002</td>
                <td align="center">0,003</td>
              </tr>
              <tr>
                <td>Peso VE/peso corporal (mg/g)</td>
                <td align="center">1,85&#177;0,13</td>
                <td align="center">1,93&#177;0,27</td>
                <td align="center">2,13&#177;0,42</td>
                <td align="center">2,10&#177;0,15</td>
                <td align="center">0,005</td>
                <td align="center">0,550</td>
                <td align="center">0,822</td>
              </tr>
              <tr>
                <td>Peso VD/peso corporal (mg/g)</td>
                <td align="center">0,46&#177;0,09</td>
                <td align="center">0,43&#177;0,05</td>
                <td align="center">0,65&#177;0,24</td>
                <td align="center">0,59&#177;0,27</td>
                <td align="center">&lt;0,001</td>
                <td align="center">0,294</td>
                <td align="center">0,776</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN1">
              <p>
                <italic>Dados expressos em m&#233;dia &#177; desvio padr&#227;o. n: n&#250;mero de animais inclu&#237;dos em cada grupo; SM: animais sham que receberam maltodextrina; SSL: animais sham que receberam suco de laranja; IM: animais infartados que receberam maltodextrina; ISL: animais infartados que receberam suco de laranja; FC: frequ&#234;ncia card&#237;aca; AE: di&#226;metro do &#225;trio esquerdo; Ao: di&#226;metro da aorta; DDVE: di&#226;metro diast&#243;lico final do ventr&#237;culo esquerdo; DSVE: di&#226;metro sist&#243;lico final do ventr&#237;culo esquerdo; IMVE: &#237;ndice da massa do ventr&#237;culo esquerdo (massa do ventr&#237;culo esquerdo/peso corporal); FAC: fractional area change (varia&#231;&#227;o da &#225;rea do ventr&#237;culo esquerdo); onda E: velocidade de movimenta&#231;&#227;o do anel mitral no in&#237;cio da di&#225;stole; onda A: velocidade de movimenta&#231;&#227;o do anel mitral no final da di&#225;stole; m&#233;dia S&#180;: velocidade m&#233;dia de movimenta&#231;&#227;o do anel mitral septal e lateral; A&#180; e E&#180; m&#233;dias: velocidade m&#233;dia de movimenta&#231;&#227;o do anel mitral septal e lateral na di&#225;stole (E&#8217;: in&#237;cio e A&#8217;: final); VE: ventr&#237;culo esquerdo/ VD: ventr&#237;culo direito; pI:valor p do efeito do infarto; pSL: valor</italic>
                <underline>
                  <italic>p</italic>
                </underline>
                <italic>do efeito do consumo de suco de laranja. pIxSL: valor p da intera&#231;&#227;o.N&#250;meros em negritorepresentam efeitos estatisticamente significativos.</italic>
                <sup>
                  <italic>a</italic>
                </sup>
                <italic>: IM&#8800;ISL;</italic>
                <sup>
                  <italic>b</italic>
                </sup>
                <italic>: SM&#8800;SSL;</italic>
                <sup>
                  <italic>A</italic>
                </sup>
                <italic>: SM&#8800;IM e</italic>
                <sup>
                  <italic>B:</italic>
                </sup>
                <italic>SSL&#8800;ISL.</italic>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </p>
      <p>Durante os tr&#234;s meses de experimento, a mortalidade foi de 5% no grupo SM (um rato morreu), 0% no grupo SSL, 22,5% no grupo IM (9 ratos morreram), e de 22,5% no grupo ISL (9 ratos morreram). Quando todos os grupos foram analisados, observou-se uma diferen&#231;a na mortalidade entre os grupos (p=0,04). Contudo, a mortalidade n&#227;o foi diferente entre os grupos infartados (p=0,836). Ap&#243;s o per&#237;odo de consumo de SL, realizou-se a eutan&#225;sia dos animais sobreviventes. Em seguida, efetuou-se a an&#225;lise histol&#243;gica do VE dos animais infartados para verificar o tamanho do infarto ( <xref ref-type="fig" rid="f01">Figura 1</xref> do material suplementar) (IM= 40,1&#177;7,41%; ISL=38,1&#177;5,76%; p= 0,528). O peso corporal final n&#227;o foi diferente entre os grupos ( <xref ref-type="table" rid="t1">Tabela 1</xref> ).</p>
      <sec>
        <title>Efeito do IM nos cora&#231;&#245;es dos ratos</title>
        <p>O IM levou &#224; RC. Quanto aos dados morfol&#243;gicos, o IM causou aumento no di&#226;metro diast&#243;lico do VE/peso corporal final, di&#226;metro sist&#243;lico do VE /peso corporal final, di&#226;metro do &#225;trio esquerdo/aorta, &#237;ndice de massa do ventr&#237;culo esquerdo (IMVE), peso do VE/peso corporal final <xref ref-type="table" rid="t1">Tabela 1</xref> ), e espessura da parede posterior do VE/peso corporal final, espessura da parede do septo interventricular/peso corporal final, e di&#226;metro atrial esquerdo/peso corporal final ( <xref ref-type="table" rid="t1">Tabela 1</xref> do material suplementar). Essas mudan&#231;as caracterizam o aumento das cavidades esquerdas e hipertrofia do VE. O IM afetou a fun&#231;&#227;o card&#237;aca sist&#243;lica, conforme os valores mais baixos da varia&#231;&#227;o de &#225;rea do VE ( <italic>fractional area change</italic> , FAC) e S&#8217; m&#233;dia ( <xref ref-type="table" rid="t1">Tabela 1</xref> ), encurtamento endoc&#225;rdico, e fra&#231;&#227;o de eje&#231;&#227;o ( <xref ref-type="table" rid="t2">Tabela 2</xref> do material suplementar). A fun&#231;&#227;o diast&#243;lica tamb&#233;m foi afetada, indicado por uma redu&#231;&#227;o na E&#8217; m&#233;dia ( <xref ref-type="table" rid="t1">Tabela 1</xref> ), tempo de desacelera&#231;&#227;o da onda E, E&#8217; lateral, e E&#8217; septal ( <xref ref-type="table" rid="t2">Tabela 2</xref> do material suplementar), e aumento na onda A, m&#233;dia da A&#8217;, raz&#227;o E/E&#8217; ( <xref ref-type="table" rid="t1">Tabela 1</xref> ), &#237;ndice de Tei, raz&#227;o E/A, tempo de relaxamento isovolum&#233;trico ajustado pela frequ&#234;ncia card&#237;aca, A&#8217; lateral e A&#8217; septal.</p>
        <p>
          <table-wrap id="t2">
            <label>Tabela 2</label>
            <caption>
              <title>&#8211; Marcadores de estresse oxidativo e marcadores inflamat&#243;rios</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Vari&#225;vel</th>
                  <th>SM (n = 8)</th>
                  <th>SSL (n = 8)</th>
                  <th>IM (n = 4)</th>
                  <th>ISL (n = 4)</th>
                  <th>p (I)</th>
                  <th>p (OJ)</th>
                  <th>p (I&#215;OJ)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>LH (nmol/g)</td>
                  <td align="center">209&#177;28,3</td>
                  <td align="center">215&#177;28,3</td>
                  <td align="center">256&#177;28,0</td>
                  <td align="center">277&#177;26,0</td>
                  <td align="center">&lt;0,001</td>
                  <td align="center">0,293</td>
                  <td align="center">0,573</td>
                </tr>
                <tr>
                  <td>Catalase (&#181;mol/g)</td>
                  <td align="center">64,4&#177;6,79</td>
                  <td align="center">61,8&#177;7,07</td>
                  <td align="center">55,4&#177;7,00</td>
                  <td align="center">58,1&#177;7,60</td>
                  <td align="center">0,056</td>
                  <td align="center">0,993</td>
                  <td align="center">0,404</td>
                </tr>
                <tr>
                  <td>SOD (nmol/mg)</td>
                  <td align="center">12,9&#177;2,83</td>
                  <td align="center">13,5&#177;2,83</td>
                  <td align="center">18,7&#177;1,80</td>
                  <td align="center">17,1&#177;1,40</td>
                  <td align="center">&lt;0,001</td>
                  <td align="center">0,639</td>
                  <td align="center">0,355</td>
                </tr>
                <tr>
                  <td>Atividade da GSH-px (nmol/mg)</td>
                  <td align="center">62,5&#177;6,51</td>
                  <td align="center">50,2&#177;7,07</td>
                  <td align="center">58,0&#177;7,00</td>
                  <td align="center">45,3&#177;6,00</td>
                  <td align="center">0,134</td>
                  <td align="center">&lt;0,001</td>
                  <td align="center">0,951</td>
                </tr>
                <tr>
                  <td>Express&#227;o da GSH-px (unidade arbitr&#225;ria)</td>
                  <td align="center">7,56&#177;7,39</td>
                  <td align="center">7,62&#177;10,8</td>
                  <td align="center">6,63&#177;5,82</td>
                  <td align="center">6,37&#177;3,78</td>
                  <td align="center">0,600</td>
                  <td align="center">0,649</td>
                  <td align="center">0,546</td>
                </tr>
                <tr>
                  <td>IL-10 (pg/mg)</td>
                  <td align="center">23,9&#177;7,92</td>
                  <td align="center">39,6&#177;13,0 <sup>b</sup></td>
                  <td align="center">42,0&#177;9,60 <sup>A</sup></td>
                  <td align="center">34,1&#177;7,60</td>
                  <td align="center">0,135</td>
                  <td align="center">0,352</td>
                  <td align="center">0,008</td>
                </tr>
                <tr>
                  <td>IFN-&#947; (pg/mg)</td>
                  <td align="center">7,1&#177;2,26</td>
                  <td align="center">13,2&#177;3,96 <sup>b</sup></td>
                  <td align="center">17,7&#177;6,80 <sup>A</sup></td>
                  <td align="center">11,2&#177;2,00 <sup>a</sup></td>
                  <td align="center">0,037</td>
                  <td align="center">0,928</td>
                  <td align="center">0,003</td>
                </tr>
                <tr>
                  <td>NF-&#954;B (unidade arbitr&#225;ria)</td>
                  <td align="center">7,03&#177;11,0</td>
                  <td align="center">4,61&#177;4,98</td>
                  <td align="center">3,40&#177;3,12</td>
                  <td align="center">6,80&#177;4,00</td>
                  <td align="center">0,942</td>
                  <td align="center">0,330</td>
                  <td align="center">0,266</td>
                </tr>
                <tr>
                  <td>p NF-&#954;B (unidade arbitr&#225;ria)</td>
                  <td align="center">5,40&#177;10,2</td>
                  <td align="center">3,18&#177;2,40</td>
                  <td align="center">3,28&#177;3,12</td>
                  <td align="center">5,22&#177;3,34</td>
                  <td align="center">0,587</td>
                  <td align="center">0,084</td>
                  <td align="center">0,980</td>
                </tr>
                <tr>
                  <td>Sirt 1 (unidade arbitr&#225;ria)</td>
                  <td align="center">1,81&#177;0,82</td>
                  <td align="center">2,34&#177;1,41</td>
                  <td align="center">2,42&#177;1,44</td>
                  <td align="center">1,65&#177;0,56</td>
                  <td align="center">0,925</td>
                  <td align="center">0,813</td>
                  <td align="center">0,203</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN2">
                <p>
                  <italic>Dados expressos em m&#233;dia &#177; desvio padr&#227;o. n: n&#250;mero de animais inclu&#237;dos em cada grupo; SM: animais sham que receberam maltodextrina; SSL: animais sham que receberam suco de laranja; IM: animais infartados que receberam maltodextrina; ISL: animais infartados que receberam suco de laranja; HL: hidroper&#243;xido lip&#237;dico; SOD: super&#243;xido dismutase; GSH-px: glutationa peroxidase; IL-10: interleucina-10; INF-&#947;: interferon- &#947;; NF-&#954;B: fator nuclear &#954;B total; e p NF-&#954;B: fator nuclear &#954;B fosforilado; Sirt 1: sirtu&#237;na 1. pI:valor p do efeito do infarto; pSL: valor <underline>p</underline> do efeito do consumo de suco de laranja. pIxSL: valor p da intera&#231;&#227;o. N&#250;meros em negrito representam efeitos estatisticamente significativos. <sup>a</sup>: IM&#8800;ISL; <sup>b</sup>: SM&#8800;SSL; <sup>A</sup>: SM&#8800;IM e <sup>B:</sup> SSL&#8800;ISL.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p>O IM tamb&#233;m aumentou o estresse oxidativo, demonstrado pelo aumento na atividade de LH e SOD ( <xref ref-type="table" rid="t2">Tabela 2</xref> ), menor express&#227;o da HO-1 (Figura 1A), e ocorreu a menor express&#227;o do Nrf-2 (Figura 1B). Os mediadores inflamat&#243;rios IL-10 e INF-&#947; foram mais altos no IM ( <xref ref-type="table" rid="t2">Tabela 2</xref> ), e n&#227;o houve diferen&#231;a nos n&#237;veis de NF-&#954;B ou Sirt-1 entre os animais infartados e n&#227;o infartados ( <xref ref-type="table" rid="t2">Tabela 2</xref> e <xref ref-type="fig" rid="f02">Figura 2</xref> do material suplementar). Observou-se maior oxida&#231;&#227;o de carboidratos que de &#225;cidos graxos, e menor metabolismo energ&#233;tico, demonstrados por maior atividade de LDH e PFK, e menor atividade de OHADH, CS, e ATP sintase. N&#227;o foi observada diferen&#231;a para a atividade do piruvato desidrogenase ( <xref ref-type="table" rid="t3">Tabela 3</xref> ).</p>
        <p>
          <fig id="f02">
            <label>Figura 2</label>
            <caption>
              <title>&#8211; Esquema ilustrativo dos principais achados do estudo.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-116-06-1127-90397-gf02.tif"/></fig>
        </p>
        <p>
          <table-wrap id="t3">
            <label>Tabela 3</label>
            <caption>
              <title>&#8211; Enzimas envolvidas no metabolismo energ&#233;tico card&#237;aco</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Vari&#225;vel</th>
                  <th>SM (n = 8)</th>
                  <th>SSL (n = 8)</th>
                  <th>IM (n = 4)</th>
                  <th>ISL (n = 4)</th>
                  <th>p (I)</th>
                  <th>p (SL)</th>
                  <th>p (I&#215;SL)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>PFK (nmol/g)</td>
                  <td align="center">128&#177;17,0</td>
                  <td align="center">112&#177;24,6</td>
                  <td align="center">139&#177;26,0</td>
                  <td align="center">178&#177;26,0 <sup>aB</sup></td>
                  <td align="center">&lt;0,001</td>
                  <td align="center">0,257</td>
                  <td align="center">0,011</td>
                </tr>
                <tr>
                  <td>LDH (nmol/mg)</td>
                  <td align="center">88,5&#177;18,7</td>
                  <td align="center">82,6&#177;18,1</td>
                  <td align="center">111&#177;18,6</td>
                  <td align="center">134&#177;16,</td>
                  <td align="center">&lt;0,001</td>
                  <td align="center">0,320</td>
                  <td align="center">0,092</td>
                </tr>
                <tr>
                  <td>PDH (nmol/g)</td>
                  <td align="center">344&#177;53,7</td>
                  <td align="center">385&#177;31,1</td>
                  <td align="center">345&#177;100</td>
                  <td align="center">341&#177;42,0</td>
                  <td align="center">0,386</td>
                  <td align="center">0,461</td>
                  <td align="center">0,376</td>
                </tr>
                <tr>
                  <td>OHADH (nmol/mg)</td>
                  <td align="center">33,2&#177;6,22</td>
                  <td align="center">33,9&#177;6,22</td>
                  <td align="center">23,8&#177;8,40</td>
                  <td align="center">24,5&#177;2,80</td>
                  <td align="center">0,003</td>
                  <td align="center">0,798</td>
                  <td align="center">0,992</td>
                </tr>
                <tr>
                  <td>CS (nmol/mg)</td>
                  <td align="center">50,0&#177;6,22</td>
                  <td align="center">49,4&#177;6,51</td>
                  <td align="center">34,5&#177;7,40</td>
                  <td align="center">40,5&#177;4,80</td>
                  <td align="center">&lt;0,001</td>
                  <td align="center">0,350</td>
                  <td align="center">0,254</td>
                </tr>
                <tr>
                  <td>ATP sintase (nmol/mg)</td>
                  <td align="center">21,0&#177;3,11</td>
                  <td align="center">27,8&#177;5,37</td>
                  <td align="center">11,4&#177;1,20</td>
                  <td align="center">15,9&#177;4,40</td>
                  <td align="center">&lt;0,001</td>
                  <td align="center">0,005</td>
                  <td align="center">0,532</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN3">
                <p>
                  <italic>Dados expressos em m&#233;dia &#177; desvio padr&#227;o. n: n&#250;mero de animais inclu&#237;dos em cada grupo; SM: animais sham que receberam maltodextrina; SSL: animais sham que receberam suco de laranja; IM: animais infartados que receberam maltodextrina; ISL: animais infartados que receberam suco de laranja; PFK: fosfofrutoquinase; LDH: lactato desidrogenase; PDH: piruvato desidrogenase; OHADH: 3-hidroxiacil coenzima-A desidrogenase; CS: citrato sintase; ATP: adenosina trifosfato. pI: valor p do efeito do infarto; pSL: valor <underline>p</underline> do efeito do consumo de suco de laranja. pIxSL: valor p da intera&#231;&#227;o. N&#250;meros em negrito representam efeitos estatisticamente significativos. <sup>a</sup>: IM&#8800;ISL; <sup>b</sup>: SM&#8800;SSL; <sup>A</sup>: SM&#8800;IM e <sup>B:</sup> SSL&#8800;ISL.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
      </sec>
      <sec>
        <title>Efeito do consumo de SL sobre o cora&#231;&#227;o</title>
        <p>A ingest&#227;o de SL causou redu&#231;&#227;o da cavidade do VE, com valores mais baixos do di&#226;metro diast&#243;lico final do VE (DDVE) e di&#226;metro sist&#243;lico final do VE (DSVE); melhorou a fun&#231;&#227;o sist&#243;lica, com valores mais altos de S&#8217; m&#233;dio; e melhorou a fun&#231;&#227;o diast&#243;lica, com menor di&#226;metro do &#225;trio esquerdo ajustado para o di&#226;metro da aorta ( <xref ref-type="table" rid="t1">Tabela 1</xref> ) <sup><xref ref-type="bibr" rid="B29">29</xref></sup> ap&#243;s o IM. N&#227;o foram observadas diferen&#231;as para outras vari&#225;veis ecocardiogr&#225;ficas ( <xref ref-type="table" rid="t1">Tabela 1</xref> ). As outras vari&#225;veis relativas &#224; fun&#231;&#227;o n&#227;o foram valorizadas devido &#224; elevada frequ&#234;ncia card&#237;aca <sup><xref ref-type="bibr" rid="B30">30</xref></sup> no grupo SL ( <xref ref-type="table" rid="t2">Tabela 2</xref> do material suplementar).</p>
        <p>Al&#233;m disso, os animais que consumiram SL apresentaram atividade mais baixa da GSH-Px ( <xref ref-type="table" rid="t2">Tabela 2</xref> ). N&#227;o foram observadas diferen&#231;as para atividade de LH, SOD, catalase, ou express&#227;o de GSH-Px ( <xref ref-type="table" rid="t2">Tabela 2</xref> e <xref ref-type="fig" rid="f02">Figura 2</xref> do material suplementar).</p>
        <p>Quanto aos mediadores inflamat&#243;rios, o grupo SSL apresentou IL-10 e INF-&#947; mais elevados em compara&#231;&#227;o ao grupo SM ( <xref ref-type="table" rid="t2">Tabela 2</xref> ). O grupo ISL apresentou valores de INF-&#947; mais baixos que o grupo IM ( <xref ref-type="table" rid="t2">Tabela 2</xref> ). N&#227;o houve diferen&#231;as para NF-&#954;B ou Sirt-1 entre os animais que consumiram e os que n&#227;o consumiram SL ( <xref ref-type="table" rid="t2">Tabela 2</xref> e <xref ref-type="fig" rid="f02">Figura 2</xref> do material suplementar).</p>
        <p>Observou-se melhora no uso de substratos nos animais que consumiram SL. Observamos valores mais altos para atividade da PFK no grupo ISL em compara&#231;&#227;o ao grupo IM, e atividade mais alta da ATP sintase nos animais que consumiram SL. N&#227;o se observou diferen&#231;as na atividade de outras enzimas do metabolismo energ&#233;tico entre os grupos ( <xref ref-type="table" rid="t3">Tabela 3</xref> ).</p>
        <p>Um resultado interessante que os animais que consumiram SL apresentaram maior express&#227;o de HO-1 (Figura 1A), apesar de n&#227;o terem apresentado diferen&#231;a na express&#227;o de Nrf2 (Figura 1B).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discuss&#227;o</title>
      <p>No presente estudo, IM induzido por liga&#231;&#227;o da art&#233;ria coron&#225;ria em ratos resultou em hipertrofia do VE e disfun&#231;&#227;o diast&#243;lica, o que foi compat&#237;vel com altera&#231;&#245;es observadas no infarto cr&#244;nico. <sup><xref ref-type="bibr" rid="B11">11</xref></sup> Nossos dados tamb&#233;m mostraram aumento no estresse oxidativo e marcadores inflamat&#243;rios, bem como altera&#231;&#245;es no metabolismo energ&#233;tico, com defici&#234;ncia na &#946;-oxida&#231;&#227;o de &#225;cidos graxos. Essas altera&#231;&#245;es caracterizam o processo de RC. <sup><xref ref-type="bibr" rid="B31">31</xref> - <xref ref-type="bibr" rid="B33">33</xref></sup> Tamb&#233;m observamos redu&#231;&#227;o na express&#227;o de Nrf-2 e HO-1. Na fase cr&#244;nica do IM, a via do Nrf2 pode estar reduzida por express&#227;o anormal do gene-alvo do Nrf2, afetando a manuten&#231;&#227;o da homeostase redox via enzimas medidas por elementos de resposta antioxidante. <sup><xref ref-type="bibr" rid="B34">34</xref></sup> Em estudo pr&#233;vio conduzido em nosso laborat&#243;rio com modelo de IM, observamos express&#227;o mais baixa de Nrf2 e HO-1. <sup><xref ref-type="bibr" rid="B3">3</xref></sup> Esses achados sugerem ou uma menor express&#227;o ou um maior catabolismo da prote&#237;na Nrf2, levando, assim, &#224; menor s&#237;ntese de HO-1.</p>
      <p>No presente estudo, o consumo de SL resultou na atenua&#231;&#227;o da RC nos animais infartados. Essa atenua&#231;&#227;o pode ser observada na diminui&#231;&#227;o da cavidade do VE (DDVE e DSVE), e na melhora da fun&#231;&#227;o sist&#243;lica, caracterizada pelo aumento no S&#8217; m&#233;dio, <sup><xref ref-type="bibr" rid="B35">35</xref></sup> e na fun&#231;&#227;o diast&#243;lica (menor di&#226;metro do &#225;trio esquerdo). No estudo de Yu et al., <sup><xref ref-type="bibr" rid="B36">36</xref></sup> os ratos infartados por liga&#231;&#227;o da art&#233;ria coron&#225;ria esquerda, tratados com hesperidina por quatro semanas, apresentaram DDVE e DSVE mais baixos e melhor fun&#231;&#227;o sist&#243;lica que os animais infartados. Esses dados s&#227;o similares aos nossos, e podem indicar o efeito da hesperidina do SL sobre o processo de RC. Em outro estudo, outro composto fen&#243;lico, a hesperetina, tamb&#233;m apresentou efeito sobre o cora&#231;&#227;o. Em um modelo de sobrecarga de press&#227;o, Deng et al., <sup><xref ref-type="bibr" rid="B37">37</xref></sup> encontraram valores mais baixos de DDVE e de DSVE oito semanas ap&#243;s a administra&#231;&#227;o de hesperetina.</p>
      <p>O IM leva a desequil&#237;brio entre a produ&#231;&#227;o de EROS e defesas antioxidantes, levando a estresse oxidativo. Ap&#243;s isquemia, algumas EROS danificam membranas celulares, iniciando o processo de peroxida&#231;&#227;o lip&#237;dica. <sup><xref ref-type="bibr" rid="B38">38</xref></sup> Por exemplo, Bagatini et al., <sup><xref ref-type="bibr" rid="B39">39</xref></sup> descreveram aumento na peroxida&#231;&#227;o lip&#237;dica em pacientes com IM. Nossos resultados tamb&#233;m mostraram maior concentra&#231;&#227;o de hidroper&#243;xidos lip&#237;dicos nos animais infartados em compara&#231;&#227;o aos animais n&#227;o infartados. <sup><xref ref-type="bibr" rid="B40">40</xref></sup> A enzima SOD &#233; a primeira defesa do organismo contra EROS. Nosso estudo mostrou que os animais infartados, em compara&#231;&#227;o aos n&#227;o infartados, apresentaram maior atividade da enzima SOD, conforme descrito anteriormente. <sup><xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B25">25</xref></sup> Em rela&#231;&#227;o ao consumo de SL, observamos que os animais que consumiram SL apresentaram menor atividade da GSH-Px. Resultado semelhante foi apresentado por Selvaraj e Pugalendi <sup><xref ref-type="bibr" rid="B41">41</xref></sup> no modelo de isquemia induzida por isoproterenol: os ratos que receberam hesperidina apresentaram atividade mais baixa das enzimas antioxidantes, entre eles, a GSH-Px. <sup><xref ref-type="bibr" rid="B41">41</xref></sup></p>
      <p>Em rela&#231;&#227;o ao metabolismo energ&#233;tico, o cora&#231;&#227;o, assim como outros &#243;rg&#227;os, consegue adaptar-se e utilizar o melhor substrato energ&#233;tico em cada situa&#231;&#227;o. A PFK atua na regula&#231;&#227;o da glic&#243;lise, e catalisa a fosforila&#231;&#227;o de glicose em frutose-6-fosfato e subsequentemente em frutose 1,6-bisfosfato. <sup><xref ref-type="bibr" rid="B42">42</xref></sup> A PFK &#233; ativada quando as concentra&#231;&#245;es de ATP s&#227;o reduzidas e &#233; inibida quando as c&#233;lulas t&#234;m reserva suficiente de ATP e de outros substratos, tais como &#225;cidos graxos. <sup><xref ref-type="bibr" rid="B42">42</xref></sup> Nossos dados mostraram valores mais altos de PFK em animais infartados com ingest&#227;o de SL. Esses dados mostram que atividade aumentada da PFK pode levar &#224; regula&#231;&#227;o da via glicol&#237;tica, fornecendo mais substrato para produ&#231;&#227;o de energia. Outro achado importante que indica maior uso de substrato &#233; a maior atividade da ATP sintase em animais que receberam SL.</p>
      <p>Al&#233;m do estresse oxidativo e altera&#231;&#245;es metab&#243;licas, observamos que os animais infartados que receberam SL apresentaram valores mais baixos de IFN-&#947;. Uma vez que a fase cr&#244;nica da inflama&#231;&#227;o est&#225; relacionada a uma produ&#231;&#227;o aumentada de IFN-&#947;, <sup><xref ref-type="bibr" rid="B43">43</xref></sup> nossos resultados sugerem uma fase mais avan&#231;ada em dire&#231;&#227;o &#224; resolu&#231;&#227;o do processo inflamat&#243;rio. Um resultado interessante &#233; que animais sham que consumiram SL mostraram efeito imunomodulat&#243;rio, indicado pelos valores mais altos de IL-10 e INF-&#947;. Similar aos nossos achados em animais do grupo sham, os quais n&#227;o sofreram nenhuma les&#227;o card&#237;aca, estudos com humanos sadios, de meia idade, relataram que o SL alterou a express&#227;o g&#234;nica em leuc&#243;citos para um perfil anti-inflamat&#243;rio e antiaterog&#234;nico, <sup><xref ref-type="bibr" rid="B44">44</xref></sup> e promoveu uma prote&#231;&#227;o precoce de c&#233;lulas sangu&#237;neas mononucleares contra dano oxidativo no DNA. <sup><xref ref-type="bibr" rid="B45">45</xref></sup> Al&#233;m disso, o consumo de SL com a refei&#231;&#227;o rica em carboidratos preveniu o estresse oxidativo e inflamat&#243;rio induzido pela refei&#231;&#227;o. <sup><xref ref-type="bibr" rid="B46">46</xref></sup></p>
      <p>Outro achado interessante em nosso estudo foi os valores mais elevados de HO-1 em animais que consumiram SL. Lin et al., <sup><xref ref-type="bibr" rid="B47">47</xref></sup> em 2005, tamb&#233;m mostraram que a hesperetina induziu a express&#227;o proteica de HO-1. <sup><xref ref-type="bibr" rid="B47">47</xref></sup> A enzima HO-1 exerce a&#231;&#227;o importante na homeostase celular devido &#224; sua a&#231;&#227;o catab&#243;lica no grupo heme das hemoprote&#237;nas, gerando subprodutos tais como ferro, biliverdina e mon&#243;xido de carbono. Por meio desses subprodutos, a HO-1 exerce a&#231;&#227;o inflamat&#243;ria antioxidante, e antiapopt&#243;tica. <sup><xref ref-type="bibr" rid="B48">48</xref> , <xref ref-type="bibr" rid="B49">49</xref></sup> Al&#233;m dessa fun&#231;&#227;o cl&#225;ssica, a HO-1 participa na sinaliza&#231;&#227;o celular amplificando a a&#231;&#227;o dos indutores (heme, oxidantes, citocinas, for&#231;as hemodin&#226;micas, fatores de crescimento, hip&#243;xia, e horm&#244;nios) de fatores de transcri&#231;&#227;o. <sup><xref ref-type="bibr" rid="B48">48</xref></sup></p>
      <p>Wang et al., <sup><xref ref-type="bibr" rid="B50">50</xref></sup> mostraram que a HO-1 &#233; importante para a homeostase card&#237;aca, protegendo o &#243;rg&#227;o contra isquemia e les&#245;es induzidas pela reperfus&#227;o, e danos oxidativos. <sup><xref ref-type="bibr" rid="B50">50</xref></sup> Em outro estudo, a administra&#231;&#227;o de hemina em camundongos infartados induziu a ativa&#231;&#227;o de HO-1, o que causou uma mudan&#231;a nos macr&#243;fagos para um fen&#243;tipo anti-inflamat&#243;rio (M2), redu&#231;&#227;o da expans&#227;o da cicatriz do infarto, e melhora da fun&#231;&#227;o card&#237;aca. <sup><xref ref-type="bibr" rid="B51">51</xref></sup> Assim, HO-1 aumentada tamb&#233;m pode exercer importante papel na atenua&#231;&#227;o da RC pelo SL ( <xref ref-type="fig" rid="f02">Figura 2</xref> ). Ainda, esse aumento foi independente da via do Nrf2, uma vez que o SL n&#227;o causou altera&#231;&#245;es na express&#227;o dessa prote&#237;na. Similar aos nossos achados, Wang et al., <sup><xref ref-type="bibr" rid="B52">52</xref></sup> encontraram que a isoliquiritina e a isoliquiritigenina, flavonoides derivados do alca&#231;uz, induziram a express&#227;o de HO-1 independentemente da express&#227;o de Nrf2. <sup><xref ref-type="bibr" rid="B52">52</xref></sup> A express&#227;o de HO-1 pode ser induzida por diferentes vias e variar de acordo com o modelo e tratamento utilizado. <sup><xref ref-type="bibr" rid="B47">47</xref></sup></p>
      <sec>
        <title>Limita&#231;&#245;es</title>
        <p>O SL usado no estudo foi um suco comercial, pronto para consumo, pasteurizado, livre de conservantes e a&#231;&#250;car. A escolha por esse suco foi para garantir a padroniza&#231;&#227;o. No entanto, &#233; poss&#237;vel que o uso de outros tipos de sucos, elaborados com outros tipos de laranjas, poderia levar a respostas diferentes.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclus&#227;o</title>
      <p>O SL atenuado por RC ap&#243;s IM, com diminui&#231;&#227;o do di&#226;metro do VE e melhora da fun&#231;&#227;o sist&#243;lica e diast&#243;lica; HO-1 pode desempenhar um papel importante neste processo.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Agradecimentos</title>
      <p>Este estudo recebeu apoio financeiro da Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES).</p>
    </ack>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Punithavathi V, Prince PSM. Pretreatment with a combination of quercetin and &#945;-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats. Life Sci. 2010;86(5):178-84.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Punithavathi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Prince</surname>
              <given-names>PSM</given-names>
            </name>
          </person-group>
          <article-title>Pretreatment with a combination of quercetin and &#945;-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats</article-title>
          <source>Life Sci</source>
          <year>2010</year>
          <volume>86</volume>
          <issue>5</issue>
          <fpage>178</fpage>
          <lpage>184</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Vasanthi H, ShriShriMal N, Das D. Phytochemicals from plants to combat cardiovascular disease. Curr Med Chem. 2012;19(14):2242-51.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vasanthi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>ShriShriMal</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Phytochemicals from plants to combat cardiovascular disease</article-title>
          <source>Curr Med Chem</source>
          <year>2012</year>
          <volume>19</volume>
          <issue>14</issue>
          <fpage>2242</fpage>
          <lpage>2251</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Rafacho BP, Santos PP, Goncalves AF, Fernandes AAH, Okoshi K, Chiuso-Minicucci F, et al. Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats. PLoS One. 2017;12(5):e0177521.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rafacho</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Goncalves</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>AAH</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chiuso-Minicucci</surname>
              <given-names>F</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats</article-title>
          <source>PLoS One</source>
          <year>2017</year>
          <volume>12</volume>
          <issue>5</issue>
          <elocation-id>e0177521</elocation-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Hyson DA. A review and critical analysis of the scientific literature related to 100% fruit juice and human health. Adv Nutr. 2015;6(1):37-51.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hyson</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>A review and critical analysis of the scientific literature related to 100% fruit juice and human health</article-title>
          <source>Adv Nutr</source>
          <year>2015</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>37</fpage>
          <lpage>51</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Vinueza JC, Faria JB, C&#233;sar TB. Hesperidina diminui o colesterol sangu&#237;neo de ratos alimentados com gordura saturada. Alim Nutr Araraquara. 2009;19(4):473-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vinueza</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Faria</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>C&#233;sar</surname>
              <given-names>TB</given-names>
            </name>
          </person-group>
          <article-title>Hesperidina diminui o colesterol sangu&#237;neo de ratos alimentados com gordura saturada</article-title>
          <source>Alim Nutr Araraquara</source>
          <year>2009</year>
          <volume>19</volume>
          <issue>4</issue>
          <fpage>473</fpage>
          <lpage>479</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Coelho RCLA, Hermsdorff HHM, Bressan J. Anti-inflammatory properties of orange juice: possible favorable molecular and metabolic effects. Plant Foods Hum Nutr. 2013;68(1):1-10.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coelho</surname>
              <given-names>RCLA</given-names>
            </name>
            <name>
              <surname>Hermsdorff</surname>
              <given-names>HHM</given-names>
            </name>
            <name>
              <surname>Bressan</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Anti-inflammatory properties of orange juice: possible favorable molecular and metabolic effects</article-title>
          <source>Plant Foods Hum Nutr</source>
          <year>2013</year>
          <volume>68</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>10</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Buttros JB, Bergamaschi CT, Ribeiro DA, Fracalossi AC, Campos RR. Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats. Pharmacology. 2009;84(1):29-37.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buttros</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Bergamaschi</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Fracalossi</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Campos</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats</article-title>
          <source>Pharmacology</source>
          <year>2009</year>
          <volume>84</volume>
          <issue>1</issue>
          <fpage>29</fpage>
          <lpage>37</lpage>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. Pereira BLB, Reis PP, Severino FE, Felix TF, Braz MG, Nogueira FR, et al. Tomato (Lycopersicon esculentum) or lycopene supplementation attenuates ventricular remodeling after myocardial infarction through different mechanistic pathways. J Nutr Biochem. 2017;46:117-24.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>BLB</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Severino</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Felix</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Braz</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Nogueira</surname>
              <given-names>FR</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Tomato (Lycopersicon esculentum) or lycopene supplementation attenuates ventricular remodeling after myocardial infarction through different mechanistic pathways</article-title>
          <source>J Nutr Biochem</source>
          <year>2017</year>
          <volume>46</volume>
          <fpage>117</fpage>
          <lpage>124</lpage>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Lustosa BB, Polegato B, Minicucci M, Rafacho B, Santos PP, Fernandes AA, et al. Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction. Int J Cardiol. 2016;225:147-53.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lustosa</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Polegato</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rafacho</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>AA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction</article-title>
          <source>Int J Cardiol</source>
          <year>2016</year>
          <volume>225</volume>
          <fpage>147</fpage>
          <lpage>153</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Paiva SA, Matsubara LS, Matsubara BB, Minicucci MF, Azevedo PS, Campana AlO, et al. Retinoic acid supplementation attenuates ventricular remodeling after myocardial infarction in rats. J Nutr. 2005;135(10):2326-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paiva</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>AlO</surname>
              <given-names>Campana</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Retinoic acid supplementation attenuates ventricular remodeling after myocardial infarction in rats</article-title>
          <source>J Nutr</source>
          <year>2005</year>
          <volume>135</volume>
          <issue>10</issue>
          <fpage>2326</fpage>
          <lpage>2328</lpage>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57(1):84-95.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pfeffer</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Pfeffer</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Influence of chronic captopril therapy on the infarcted left ventricle of the rat</article-title>
          <source>Circ Res</source>
          <year>1985</year>
          <volume>57</volume>
          <issue>1</issue>
          <fpage>84</fpage>
          <lpage>95</lpage>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. Zornoff LAM, Paiva SARd, Minicucci MF, Spadaro J. Infarto do mioc&#225;rdio experimental em ratos: an&#225;lise do modelo. Arq Bras Cardiol. 2009;93(4):434-40.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zornoff</surname>
              <given-names>LAM</given-names>
            </name>
            <name>
              <surname>SARd</surname>
              <given-names>Paiva</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Spadaro</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Infarto do mioc&#225;rdio experimental em ratos: an&#225;lise do modelo</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2009</year>
          <volume>93</volume>
          <issue>4</issue>
          <fpage>434</fpage>
          <lpage>440</lpage>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. The Lancet. 2006;367(9507):356-67.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Opie</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Commerford</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Gersh</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Pfeffer</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Controversies in ventricular remodelling</article-title>
          <source>The Lancet</source>
          <year>2006</year>
          <volume>367</volume>
          <issue>9507</issue>
          <fpage>356</fpage>
          <lpage>367</lpage>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. Zornoff LAM, Cicogna AC, Paiva SAR, Spadaro J. Remodelamento e seu impacto na progress&#227;o da disfun&#231;&#227;o ventricular. Rev Soc Cardiol Estado de S&#228;o Paulo. 2002;12(3):371-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zornoff</surname>
              <given-names>LAM</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Paiva</surname>
              <given-names>SAR</given-names>
            </name>
            <name>
              <surname>Spadaro</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Remodelamento e seu impacto na progress&#227;o da disfun&#231;&#227;o ventricular</article-title>
          <source>Rev Soc Cardiol Estado de S&#228;o Paulo</source>
          <year>2002</year>
          <volume>12</volume>
          <issue>3</issue>
          <fpage>371</fpage>
          <lpage>378</lpage>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Zornoff LA, Paiva SA, Duarte DR, Spadaro J. Ventricular remodeling after myocardial infarction: concepts and clinical implications. Arq Bras Cardiol. 2009;92(2):157-64.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zornoff</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Paiva</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Duarte</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Spadaro</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ventricular remodeling after myocardial infarction: concepts and clinical implications</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2009</year>
          <volume>92</volume>
          <issue>2</issue>
          <fpage>157</fpage>
          <lpage>164</lpage>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res. 2008;81(3):482-90.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Myocardial repair/remodelling following infarction: roles of local factors</article-title>
          <source>Cardiovasc Res</source>
          <year>2008</year>
          <volume>81</volume>
          <issue>3</issue>
          <fpage>482</fpage>
          <lpage>490</lpage>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17. Raghunath A, Sundarraj K, Nagarajan R, Arfuso F, Jinsong B, Kumar AP, et al. Antioxidant response elements: Discovery, classes, regulation and potential applications. Redox Biol. 2018;17:297-314.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raghunath</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sundarraj</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nagarajan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Arfuso</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jinsong</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>AP</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Antioxidant response elements: Discovery, classes, regulation and potential applications</article-title>
          <source>Redox Biol</source>
          <year>2018</year>
          <volume>17</volume>
          <fpage>297</fpage>
          <lpage>314</lpage>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007;59(4):418-58.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferdinandy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Baxter</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
          <article-title>Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning</article-title>
          <source>Pharmacol Rev</source>
          <year>2007</year>
          <volume>59</volume>
          <issue>4</issue>
          <fpage>418</fpage>
          <lpage>458</lpage>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19. Csonka C, Kupai K, Kocsis GF, Nov&#225;k G, Fekete V, Bencsik P, et al. Measurement of myocardial infarct size in preclinical studies. J Pharmacol Tox Met. 2010;61(2):163-70.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Csonka</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kupai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kocsis</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Nov&#225;k</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fekete</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bencsik</surname>
              <given-names>P</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Measurement of myocardial infarct size in preclinical studies</article-title>
          <source>J Pharmacol Tox Met</source>
          <year>2010</year>
          <volume>61</volume>
          <issue>2</issue>
          <fpage>163</fpage>
          <lpage>170</lpage>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20. Azevedo PS, Polegato BF, Minicucci MF, Paiva SA, Zornoff LA. Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. 2016;106(1):62-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azevedo</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Polegato</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Paiva</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Zornoff</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2016</year>
          <volume>106</volume>
          <issue>1</issue>
          <fpage>62</fpage>
          <lpage>69</lpage>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: new insights. Circulation. 2011;123(24):2870-91.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mozaffarian</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Appel</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Van Horn</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Components of a cardioprotective diet: new insights</article-title>
          <source>Circulation</source>
          <year>2011</year>
          <volume>123</volume>
          <issue>24</issue>
          <fpage>2870</fpage>
          <lpage>2891</lpage>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22. Zornoff LA, Paiva SA, Minicucci MF, Spadaro J. Experimental myocardium infarction in rats: analysis of the model. Arq Bras Cardiol. 2009;93(4):434-40.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zornoff</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Paiva</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Spadaro</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Experimental myocardium infarction in rats: analysis of the model</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2009</year>
          <volume>93</volume>
          <issue>4</issue>
          <fpage>434</fpage>
          <lpage>440</lpage>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23. Pfeffer JM, Finn PV, Zornoff LA, Pfeffer MA. Endothelin-A receptor antagonism during acute myocardial infarction in rats. Cardiovasc. Drugs Ther. 2000;14(6):579-87.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pfeffer</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Finn</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Zornoff</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Pfeffer</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Endothelin-A receptor antagonism during acute myocardial infarction in rats</article-title>
          <source>Cardiovasc. Drugs Ther</source>
          <year>2000</year>
          <volume>14</volume>
          <issue>6</issue>
          <fpage>579</fpage>
          <lpage>587</lpage>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24. Minicucci MF, Azevedo PS, Martinez PF, Lima AR, Bonomo C, Guizoni DM, et al. Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats. Int J Cardiol. 2011;151(2):242-3.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Bonomo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guizoni</surname>
              <given-names>DM</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats</article-title>
          <source>Int J Cardiol</source>
          <year>2011</year>
          <volume>151</volume>
          <issue>2</issue>
          <fpage>242</fpage>
          <lpage>243</lpage>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25. Gon&#231;alves A, Santos P, Rafacho B, Silva R, Batista D, Claro R, et al. Effects of Zinc Supplementation on Cardiac Remodeling After Experimental Myocardial Infarction. FASEB J. 2015;29(1):LB348.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gon&#231;alves</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rafacho</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Batista</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Claro</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Effects of Zinc Supplementation on Cardiac Remodeling After Experimental Myocardial Infarction</article-title>
          <source>FASEB J</source>
          <year>2015</year>
          <volume>29</volume>
          <issue>1</issue>
          <size units="pages">LB348</size>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26. Zornoff LA, Matsubara BB, Matsubara LS, Azevedo PS, Minicucci MF, Campana AO, et al. &#946;-Carotene supplementation results in adverse ventricular remodeling after acute myocardial infarction. Nutrition. 2006;22(2):146-51.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zornoff</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Campana</surname>
              <given-names>AO</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>&#946;-Carotene supplementation results in adverse ventricular remodeling after acute myocardial infarction</article-title>
          <source>Nutrition</source>
          <year>2006</year>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>146</fpage>
          <lpage>151</lpage>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27. Paiva SA, Novo R, Matsubara BB, Matsubara LS, Azevedo PS, Minicucci MF, et al. &#946;-carotene attenuates the paradoxical effect of tobacco smoke on the mortality of rats after experimental myocardial infarction. J Nutr. 2005;135(9):2109-13.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paiva</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Novo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>&#946;-carotene attenuates the paradoxical effect of tobacco smoke on the mortality of rats after experimental myocardial infarction</article-title>
          <source>J Nutr</source>
          <year>2005</year>
          <volume>135</volume>
          <issue>9</issue>
          <fpage>2109</fpage>
          <lpage>2113</lpage>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233-71.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lang</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Badano</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Mor-Avi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Afilalo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ernande</surname>
              <given-names>L</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging</article-title>
          <source>Eur Heart J Cardiovasc Imaging</source>
          <year>2015</year>
          <volume>16</volume>
          <issue>3</issue>
          <fpage>233</fpage>
          <lpage>271</lpage>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation>29. Spadaro J, Fishbein M, Hare C, Pfeffer M, Maroko P. Characterization of myocardial infarcts in the rat. Arch Pathol Lab Med. 1980;104(4):179-83.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spadaro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fishbein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pfeffer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maroko</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Characterization of myocardial infarcts in the rat</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1980</year>
          <volume>104</volume>
          <issue>4</issue>
          <fpage>179</fpage>
          <lpage>183</lpage>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30. Burns AT, Connelly KA, La Gerche A, Mooney DJ, Chan J, MacIsaac AI, et al. Effect of heart rate on tissue Doppler measures of diastolic function. Echocardiography. 2007;24(7):697-701.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burns</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Connelly</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>La Gerche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mooney</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>MacIsaac</surname>
              <given-names>AI</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Effect of heart rate on tissue Doppler measures of diastolic function</article-title>
          <source>Echocardiography</source>
          <year>2007</year>
          <volume>24</volume>
          <issue>7</issue>
          <fpage>697</fpage>
          <lpage>701</lpage>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation>31. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet. 2006;28;367(9507):356-67.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Opie</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Commerford</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Gersh</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Pfeffer</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Controversies in ventricular remodelling</article-title>
          <source>Lancet</source>
          <year>2006</year>
          <comment>28</comment>
          <volume>367</volume>
          <issue>9507</issue>
          <fpage>356</fpage>
          <lpage>367</lpage>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation>32. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85(3):1093-129.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stanley</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Recchia</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Lopaschuk</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>Myocardial substrate metabolism in the normal and failing heart</article-title>
          <source>Physiol Rev</source>
          <year>2005</year>
          <volume>85</volume>
          <issue>3</issue>
          <fpage>1093</fpage>
          <lpage>1129</lpage>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation>33. Goncalves AF, Santos PP, Rafacho BP, Batista DF, Azevedo PS, Minicucci MF, et al. Vitamin D supplementation intensifies cardiac remodeling after experimental myocardial infarction. Int J Cardiol. 2014;176(3):1225-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goncalves</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Rafacho</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Batista</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Minicucci</surname>
              <given-names>MF</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Vitamin D supplementation intensifies cardiac remodeling after experimental myocardial infarction</article-title>
          <source>Int J Cardiol</source>
          <year>2014</year>
          <volume>176</volume>
          <issue>3</issue>
          <fpage>1225</fpage>
          <lpage>1226</lpage>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation>34. Yet S-F, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001;89(2):168-73.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yet</surname>
              <given-names>S-F</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Layne</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>ZY</given-names>
            </name>
            <name>
              <surname>Maemura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Solovyeva</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice</article-title>
          <source>Circ Res</source>
          <year>2001</year>
          <volume>89</volume>
          <issue>2</issue>
          <fpage>168</fpage>
          <lpage>173</lpage>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation>35. Husebye T, Eritsland J, Bj&#248;rnerheim R, Andersen GO. Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure. Eur Heart J Acute Cardiovasc Care. 2018;7(4):321-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Husebye</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eritsland</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bj&#248;rnerheim</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>GO</given-names>
            </name>
          </person-group>
          <article-title>Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure</article-title>
          <source>Eur Heart J Acute Cardiovasc Care</source>
          <year>2018</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>321</fpage>
          <lpage>329</lpage>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation>36. Yu HY, Ahn JH, Park SW, Jung Y-S. Preventive effect of Yuzu and hesperidin on left ventricular remodeling and dysfunction in rat permanent left anterior descending coronary artery occlusion model. PLoS One. 2015;10(1):e110596.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Ahn</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>Y-S</given-names>
            </name>
          </person-group>
          <article-title>Preventive effect of Yuzu and hesperidin on left ventricular remodeling and dysfunction in rat permanent left anterior descending coronary artery occlusion model</article-title>
          <source>PLoS One</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>1</issue>
          <elocation-id>e110596</elocation-id>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation>37. Deng W, Jiang D, Fang Y, Zhou H, Cheng Z, Lin Y, et al. Hesperetin protects against cardiac remodelling induced by pressure overload in mice. J Mol Histol. 2013;44(5):575-85.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Hesperetin protects against cardiac remodelling induced by pressure overload in mice</article-title>
          <source>J Mol Histol</source>
          <year>2013</year>
          <volume>44</volume>
          <issue>5</issue>
          <fpage>575</fpage>
          <lpage>585</lpage>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation>38. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res. 2009;81(3):457-64.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and left ventricular remodelling after myocardial infarction</article-title>
          <source>Cardiovasc Res</source>
          <year>2009</year>
          <volume>81</volume>
          <issue>3</issue>
          <fpage>457</fpage>
          <lpage>464</lpage>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation>39. Bagatini MD, Martins CC, Battisti V, Gasparetto D, Da Rosa CS, Spanevello RM, et al. Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels. 2011;26(1):55-63.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bagatini</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Battisti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gasparetto</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Da Rosa</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Spanevello</surname>
              <given-names>RM</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction</article-title>
          <source>Heart Vessels</source>
          <year>2011</year>
          <volume>26</volume>
          <issue>1</issue>
          <fpage>55</fpage>
          <lpage>63</lpage>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation>40. Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liguori</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Curcio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bulli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aran</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Della-Morte</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Oxidative stress, aging, and diseases</article-title>
          <source>Clin Interv Aging</source>
          <year>2018</year>
          <volume>13</volume>
          <size units="pages">757</size>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation>41. Selvaraj P, Pugalendi KV. Hesperidin, a flavanone glycoside, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats. Redox Rep. 2010;15(5):217-23.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Selvaraj</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pugalendi</surname>
              <given-names>KV</given-names>
            </name>
          </person-group>
          <article-title>Hesperidin, a flavanone glycoside, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats</article-title>
          <source>Redox Rep</source>
          <year>2010</year>
          <volume>15</volume>
          <issue>5</issue>
          <fpage>217</fpage>
          <lpage>223</lpage>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation>42. Depre C, Rider MH, Hue L. Mechanisms of control of heart glycolysis. FEBS J. 1998;258(2):277-90.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Depre</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rider</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Hue</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of control of heart glycolysis</article-title>
          <source>FEBS J</source>
          <year>1998</year>
          <volume>258</volume>
          <issue>2</issue>
          <fpage>277</fpage>
          <lpage>290</lpage>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation>43. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 2009;104(2):e9-e18.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krishnamurthy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rajasingh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lambers</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Losordo</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Kishore</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR</article-title>
          <source>Circ Res</source>
          <year>2009</year>
          <volume>104</volume>
          <issue>2</issue>
          <fpage>e9</fpage>
          <lpage>e18</lpage>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation>44. Milenkovic D, Deval C, Dubray C, Mazur A, Morand C. Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One. 2011;6(11).</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milenkovic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Deval</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dubray</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mazur</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morand</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <issue>11</issue>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation>45. Guarnieri S, Riso P, Porrini M. Orange juice vs vitamin C: effect on hydrogen peroxide-induced DNA damage in mononuclear blood cells. Br J Nutr. 2007;97(4):639-43.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guarnieri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Riso</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Porrini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Orange juice vs vitamin C: effect on hydrogen peroxide-induced DNA damage in mononuclear blood cells</article-title>
          <source>Br J Nutr</source>
          <year>2007</year>
          <volume>97</volume>
          <issue>4</issue>
          <fpage>639</fpage>
          <lpage>643</lpage>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation>46. Ghanim H, Sia CL, Upadhyay M, Korzeniewski K, Viswanathan P, Abuaysheh S, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr. 2010;91(4):940-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghanim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sia</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Upadhyay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Korzeniewski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Viswanathan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Abuaysheh</surname>
              <given-names>S</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression</article-title>
          <source>Am J Clin Nutr</source>
          <year>2010</year>
          <volume>91</volume>
          <issue>4</issue>
          <fpage>940</fpage>
          <lpage>949</lpage>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation>47. Lin HY, Shen SC, Chen YC. Anti-inflammatory effect of heme oxygenase 1: Glycosylation and nitric oxide inhibition in macrophages. J Cell Physiol. 2005;202(2):579-90.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
          <article-title>Anti-inflammatory effect of heme oxygenase 1: Glycosylation and nitric oxide inhibition in macrophages</article-title>
          <source>J Cell Physiol</source>
          <year>2005</year>
          <volume>202</volume>
          <issue>2</issue>
          <fpage>579</fpage>
          <lpage>590</lpage>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation>48. Czibik G, Derumeaux G, Sawaki D, Valen G, Motterlini R. Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology. Basic Res Cardiol. 2014;109(6):450.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Czibik</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Derumeaux</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sawaki</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Valen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Motterlini</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology</article-title>
          <source>Basic Res Cardiol</source>
          <year>2014</year>
          <volume>109</volume>
          <issue>6</issue>
          <size units="pages">450</size>
        </element-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation>49. Takagi T, Naito Y, Mizuhima K, Hirai Y, Harusato A, Okayama T, et al. Heme oxygenase-1 prevents murine intestinal inflammation. J Clin Biochem Nutr. 2018:17-133.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takagi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Naito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mizuhima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hirai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Harusato</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Okayama</surname>
              <given-names>T</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Heme oxygenase-1 prevents murine intestinal inflammation</article-title>
          <source>J Clin Biochem Nutr</source>
          <year>2018</year>
          <fpage>17</fpage>
          <lpage>133</lpage>
        </element-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation>50. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 2010;121(17):1912-25.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hamid</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Keith</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Partridge</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Xiang</surname>
              <given-names>X</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart</article-title>
          <source>Circulation</source>
          <year>2010</year>
          <volume>121</volume>
          <issue>17</issue>
          <fpage>1912</fpage>
          <lpage>1925</lpage>
        </element-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation>51. Ben-Mordechai T, Kain D, Holbova R, Landa N, Levin L-P, Elron-Gross I, et al. Targeting and modulating infarct macrophages with hemin formulated in designed lipid-based particles improves cardiac remodeling and function. J Control Release. 2017;257:21-31.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ben-Mordechai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kain</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Holbova</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Landa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Levin</surname>
              <given-names>L-P</given-names>
            </name>
            <name>
              <surname>Elron-Gross</surname>
              <given-names>I</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Targeting and modulating infarct macrophages with hemin formulated in designed lipid-based particles improves cardiac remodeling and function</article-title>
          <source>J Control Release</source>
          <year>2017</year>
          <volume>257</volume>
          <fpage>21</fpage>
          <lpage>31</lpage>
        </element-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation>52. Wang R, Zhang CY, Bai LP, Pan HD, Shu LM, Kong A-NT, et al. Flavonoids derived from liquorice suppress murine macrophage activation by up-regulating heme oxygenase-1 independent of Nrf2 activation. Int Immunopharmacol. 2015;28(2):917-24.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>A-NT</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Flavonoids derived from liquorice suppress murine macrophage activation by up-regulating heme oxygenase-1 independent of Nrf2 activation</article-title>
          <source>Int Immunopharmacol</source>
          <year>2015</year>
          <volume>28</volume>
          <issue>2</issue>
          <fpage>917</fpage>
          <lpage>924</lpage>
        </element-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="other">
        <p>Vincula&#231;&#227;o acad&#234;mica</p>
        <p>Este artigo &#233; parte de tese de mestrado de Bruna Camargo de Oliveira pela Universidade Estadual Paulista J&#250;lio de Mesquita Filho Campus de Botucatu - Faculdade de Medicina.</p>
      </fn>
    </fn-group>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Fontes de financiamento</bold>:  O presente estudo foi parcialmente financiado pela CAPES.</p>
      </fn>
    </fn-group>
    <app-group>
      <app id="app1">
        <title>* Material suplementar</title>
        <p>Para informa&#231;&#227;o adicional, por favor, clique aqui.</p>
        <supplementary-material id="suppl1" mime-subtype="pdf" mimetype="application" xlink:href=""/>
      </app>
    </app-group>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Influence of Consumption of Orange Juice (Citrus Sinensis) on Cardiac Remodeling of Rats Submitted to Myocardial Infarction</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-8825-6980</contrib-id>
          <name>
            <surname>Oliveira</surname>
            <given-names>Bruna C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-1159-5030</contrib-id>
          <name>
            <surname>Santos</surname>
            <given-names>Priscila P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueiredo</surname>
            <given-names>Amanda M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rafacho</surname>
            <given-names>Bruna P. M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ishikawa</surname>
            <given-names>Larissa</given-names>
          </name>
          <xref ref-type="aff" rid="aff2001">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-0607-8189</contrib-id>
          <name>
            <surname>Zanati</surname>
            <given-names>Silm&#233;ia G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Ana A. H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2001">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azevedo</surname>
            <given-names>Paula S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-2875-9532</contrib-id>
          <name>
            <surname>Polegato</surname>
            <given-names>Bertha F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-9831-8820</contrib-id>
          <name>
            <surname>Zornoff</surname>
            <given-names>Leonardo A. M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-5980-4367</contrib-id>
          <name>
            <surname>Minicucci</surname>
            <given-names>Marcos F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-4412-1990</contrib-id>
          <name>
            <surname>Paiva</surname>
            <given-names>Sergio A. R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff3001">
            <sup>3</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1001">
        <label>1</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Universidade Estadual Paulista J&#250;lio de Mesquita Filho Campus de Botucatu - Faculdade de Medicina de Botucatu, Botucatu, SP - Brazil</institution>
      </aff>
      <aff id="aff2001">
        <label>2</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto de Bioci&#234;ncias Campus de Botucatu (UNESP), Botucatu, SP - Brazil</institution>
      </aff>
      <aff id="aff3001">
        <label>3</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Food Research Center FoRC, S&#227;o Paulo, SP - Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c01001">Mailing Address: Sergio A. R. Paiva &#8226; Faculdade de Medicina de Botucatu - Rubi&#227;o J&#250;nior, Postal Code 18618-970, Botucatu, SP - Brazil E-mail:sergio.paiva@unesp.br</corresp>
        <fn fn-type="con">
          <p>Author Contributions</p>
          <p>Conception and design of the research: Oliveira BC, Santos PP, Rafacho BPM, Azevedo PS, Polegato BF, Zornoff LAM, Minicucc MFI, Paiva SAR; Acquisition of data: Oliveira BC, Figueiredo AM, Ishikawa L, Zanati SG, Fernandes AAH; Analysis and interpretation of the data: Oliveira BC, Santos PP, Figueiredo AM, Rafacho BPM, Ishikawa L, Zanati SG, Fernandes AAH, Azevedo PS, Polegato BF, Zornoff LAM, Minicucc MFI, Paiva SAR; Statistical analysis and Writing of the manuscript: Oliveira BC, Paiva SAR; Critical revision of the manuscript for intellectual contente: Santos PP, Azevedo PS, Polegato BF, Zornoff LAM, Minicucc MFI, Paiva SAR.</p>
        </fn>
        <fn fn-type="conflict">
          <p>Potential Conflict of Interest</p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background</title>
          <p>Orange juice (OJ) is rich in polyphenols with anti-inflammatory and antioxidant properties. After myocardial infarction (MI), complex changes occur in cardiac structure and function, which is known as cardiac remodeling (CR). Oxidative stress and inflammation can modulate this process. We hypothesized that the consumption of OJ attenuates the CR after MI.</p>
        </sec>
        <sec>
          <title>Objectives</title>
          <p>To evaluate the influence of OJ on CR after MI by analysis of functional, morphological, oxidative stress, inflammation, and energy metabolism variables.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>A total of 242 male rats weighing 200-250 g were submitted to a surgical procedure (coronary artery ligation or simulated surgery). Seven days after surgery, survivors were assigned to one of the four groups 1) SM, sham animals with water and maltodextrin (n= 20); 2) SOJ, sham animals with OJ (n= 20); 3) IM, infarcted animals with water and maltodextrin (n= 40); and 4) IOJ, infarcted animals with OJ (n = 40). Statistical analysis was performed by the two-way ANOVA supplemented by Holm-Sidak. Results are presented as mean &#177; standard deviation, the level of significance adopted was 5%.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>After 3 months, MI led to left ventricular (LV) hypertrophy, with systolic and diastolic dysfunction, and increased oxidative stress and inflammatory mediators. OJ intake reduced LV cavity and improved systolic and diastolic function. The OJ animals presented lower activity of glutathione peroxidase and higher expression of heme-oxygenase-1 (HO-1).</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>OJ attenuated CR in infarcted rats and HO-1 may be play an important role in this process.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Myocardial Infarction</kwd>
        <kwd>Fruits Juices (orange)</kwd>
        <kwd>Polyphenols</kwd>
        <kwd>Ventricular Remodeling</kwd>
        <kwd>Anti-Inflammatory Agents</kwd>
        <kwd>Antioxidants</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec sec-type="intro">
        <title>Introduction</title>
        <p>The name <italic>polyphenols</italic> , or <italic>phenolic compounds</italic> , refers to a large group of molecules found in leaf vegetables, fruits, cereals, tea, coffee, cocoa, wine, soy, and fruit juice.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> These compounds have been studied because of their potential biological effect in prevention and treatment of different diseases.<sup><xref ref-type="bibr" rid="B2">2</xref> , <xref ref-type="bibr" rid="B3">3</xref></sup></p>
        <p>In a review of the literature, Hyson showed that fruit juices, defined as pure juice or 100% fruit juice, retained most of nutrients and phytochemicals of the whole fruit and therefore may have an important potential to benefit and protect human health.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Orange juice (OJ) is a source of phenolic compounds in the form of different flavonoids. The main flavonoid of interest is hesperidin and its hydrolyzed form, hesperetin.<sup><xref ref-type="bibr" rid="B5">5</xref></sup> The research interest in the properties of OJ has increased because of its anti-inflammatory and antioxidant action in chronic diseases.<sup><xref ref-type="bibr" rid="B6">6</xref></sup></p>
        <p>For example, in myocardial injury, antioxidant supplements may have beneficial effects in cardiac remodeling (CR). In studies using myocardial infarction (MI) model, bioactive compounds present in rosemary, tomato, green tea, and antioxidants such as ascorbic acid, quercetin, alpha-tocopherol, and vitamin A showed protection against CR.<sup><xref ref-type="bibr" rid="B1">1</xref> , <xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B7">7</xref> - <xref ref-type="bibr" rid="B10">10</xref></sup></p>
        <p>Ischemic heart disease, including MI, is a leading cause of heart failure and death worldwide. After MI, complex changes in the left ventricle can cause changes in cardiac size, mass, geometry, and function.<sup><xref ref-type="bibr" rid="B11">11</xref> , <xref ref-type="bibr" rid="B12">12</xref></sup> These changes are defined as CR and can lead to heart failure and increased mortality.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> Many factors may be involved in CR, such as oxidative stress, inflammation, fibrosis, and apoptosis.<sup><xref ref-type="bibr" rid="B14">14</xref> , <xref ref-type="bibr" rid="B15">15</xref></sup></p>
        <p>In MI, ischemia initiates the generation of reactive oxygen species (ROS). ROS directly damage cell membranes, activate the inflammatory response, and lead to cell death. They can also act as transduction signals, stimulating nuclear factor &#954;B (NF-&#954;B), which, in turn, stimulates proinflammatory cytokines synthesis.<sup><xref ref-type="bibr" rid="B14">14</xref> - <xref ref-type="bibr" rid="B16">16</xref></sup> In addition, the Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 (KEAP-1/Nrf2) system could be activated during cellular oxidative stress and play a critical role in redox homeostasis. This is a universal mechanism that acts in Nrf2 target genes called antioxidant response elements. Glutathione peroxidase (GSH-Px) and heme-oxygenase-1 (HO-1) are examples of proteins regulated by this system.<sup><xref ref-type="bibr" rid="B17">17</xref></sup></p>
        <p>Therapeutic strategies to attenuate CR after MI have been extensively studied.<sup><xref ref-type="bibr" rid="B18">18</xref> , <xref ref-type="bibr" rid="B19">19</xref></sup> Aldosterone blockers, angiotensin-converting enzyme inhibitors, and beta-blockers are some of these strategies.<sup><xref ref-type="bibr" rid="B20">20</xref></sup> In this context, bioactive compounds of natural products, with cardioprotective properties such as flavonoids, can be an important adjuvant in the treatment of MI. On the other hand, studies show that a focus on food and dietary patterns instead of individual nutrients or phytochemicals is better for cardiometabolic health.<sup><xref ref-type="bibr" rid="B21">21</xref></sup> Thus, the aim of this study was to evaluate the influence of OJ intake on CR after MI.</p>
      </sec>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <sec>
          <title>Experimental protocol</title>
          <p>All experiments and procedures were performed in accordance with the National Institutes of Health&#8217;s (NIH) Guide for the Care and Use of Laboratory Animals and were approved by the Ethics Committee for Animal Experimentation of the Botucatu Medical School, UNESP, S&#227;o Paulo, Brazil (1126/2015). A total of 242 male Wistar rats weighing 200 to 250 g were used in this study. MI was induced by coronary artery ligation, as previously described.<sup><xref ref-type="bibr" rid="B22">22</xref> , <xref ref-type="bibr" rid="B23">23</xref></sup></p>
          <p>After surgery, the animals were placed in boxes with six animals each. Seven days after surgical procedure, the first echocardiographic study was performed to evaluate the efficacy of the surgical procedure.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> Then, the animals were randomly placed in boxes with two animals each, to receive either OJ or a maltodextrin (M) solution. The groups were 1) SM, sham animals that received M solution (n = 20); 2) SOJ, sham animals that received OJ (n = 20); 3) IM, infarcted animals that received M solution intake (n = 40); and 4) IOJ, infarcted animals that received OJ (n = 40). The sample size used was based on other studies from our laboratory.<sup><xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B8">8</xref> , <xref ref-type="bibr" rid="B25">25</xref></sup> The number of rats in the infarcted groups was higher, since the expected mortality in these animals during the experimental period is around 50%. In addition, only rats with a left ventricular (LV) infarcted area greater than 30% were included.<sup><xref ref-type="bibr" rid="B24">24</xref></sup></p>
          <p>Food was supplied <italic>ad libitum</italic> . The animals were treated for 3 months, and mortality was observed in this period ( <xref ref-type="fig" rid="f01001">Figure 1</xref> of the supplementary data). The rats were housed in a temperature-controlled room (22 &#177; 2&#176;C) with a 12-h light/12-h dark cycle.</p>
          <p>
            <fig id="f01001">
              <label>Figure 1</label>
              <caption>
                <title>&#8211; Nuclear factor erythroid 2-related factor 2 (Nrf2) and heme-oxygenase-1 (HO-1) expression in sham and infarcted rats by Western blot. Bar chart showing the expression of Nrf2 and HO-1 proteins in each group (A) Nrf2 expression and representative Western blot; sample size: 8 in each group. (B) HO-1 expression and representative Western blot; sample size: SM = 5; SOJ = 6; IM = 5; IOJ = 5. GAPDH glyceraldehyde-3-phosphate dehydrogenase. Data are expressed as mean &#177; SD. p(I): p value between non-infarcted animals vs. infarcted animals; p(OJ): p value between animals that received maltodextrin vs. animals that received orange juice; p(IxOJ): p-value for the interaction between the factors of infarction and orange juice intake.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-116-06-1127-90397-gf01-en.tif"/></fig>
          </p>
        </sec>
        <sec>
          <title>Coronary artery ligation</title>
          <p>MI was conducted by coronary artery ligation, as previously described.<sup><xref ref-type="bibr" rid="B22">22</xref> , <xref ref-type="bibr" rid="B23">23</xref></sup> In brief, the rats were anesthetized with ketamine (70 mg/Kg) and xylazine (1 mg/Kg), and after a left thoracotomy, the heart was exteriorized. The left atrium was retracted to facilitate the ligation of the left coronary artery with 5-0 mononylon between the pulmonary outflow tract and the left atrium. The heart was then replaced in the thorax, the lungs were inflated by positive pressure, and the thoracotomy was closed. A sham group, in which animals were submitted to surgery but without coronary occlusion, was also created. After anesthetic effect, the rats were medicated orally with metamizole sodium (30 mg / kg Dipirona&#174;, Biovet, Vargem Grande Paulista, Sao Paulo, Brazil).</p>
        </sec>
        <sec>
          <title>Orange juice</title>
          <p>Supplemented groups (SOJ and IOJ) received OJ <italic>ad libitum</italic> . Control groups (SM and IM) received a solution of water and M at a concentration of 100 g/L. The M solution was given to control animals to provide the same amount of carbohydrates as the OJ. Treatment began seven days after surgery. The OJ and M solutions were changed every 24 hours, and intake was monitored daily. Nutritional composition of the OJ is shown in supplementary data.</p>
        </sec>
        <sec>
          <title>Echocardiographic study</title>
          <p>After three months, all rats were weighed and evaluated by transthoracic echocardiography.<sup><xref ref-type="bibr" rid="B26">26</xref> , <xref ref-type="bibr" rid="B27">27</xref></sup> For the echocardiographic study, the rats were anaesthetized with intramuscular injection of ketamine (50 mg/kg) and xylazine (1 mg/kg) solution. All measurements were made by the same observer, according to the leading-edge method recommended by the American Society of Echocardiography/European Association of Echocardiography.<sup><xref ref-type="bibr" rid="B28">28</xref></sup> Echocardiography was performed with the General Electric Vivid S6 System (GE Medical Systems, Tirat Carmel, Israel) equipped with a 5- to 12-MHz phased array transducer.</p>
          <p>After echocardiography, the animals were euthanized with a large dose of pentobarbital, and their hearts were removed. The left ventricle was isolated and LV samples were immediately frozen and stored at &#8211;80&#176;C. One transverse section of the LV was separated and fixed in 10% buffered formalin and was then embedded in paraffin for histological study.</p>
        </sec>
        <sec>
          <title>Morphometric analysis</title>
          <p>Five-micrometer-thick sections were stained with hematoxylin and eosin for calculations of infarction size as previously described. All animals were included in the morphometric analysis. After infarction size calculation, infarcted animals with less than 30% of LV infarcted area were excluded from analysis. All images were collected with a video camera attached to Leica microscope; the images were analyzed with the Image-Pro Plus 3.0 software program (Media Cybernetics, Silver Spring, MD).</p>
        </sec>
        <sec>
          <title>Cardiac lipid hydroperoxide, antioxidant enzyme activity, and cardiac energy metabolism</title>
          <p>LV samples (100 mg) were used to determine total protein and lipid hydroperoxide (LH) concentrations, and activity of the following antioxidant enzymes &#8211; GPx (E.C.1.11.1.9), superoxide dismutase (SOD, E.C.1.15.1.1), and catalase (E.C.1.11.1.6). Cardiac energy metabolism was assessed by 3-hydroxyacyl coenzyme-A dehydrogenase (OHADH; E.C.1.1.1.35.), phosphofructokinase (PFK; E.C.2.7.1.11), lactate dehydrogenase (LDH; E.C.1.1.1.27), pyruvate dehydrogenase (E.C.1.2.4.1), citrate synthase (CS; E.C.4.1.3.7.), and adenosine triphosphate (ATP) synthase (EC 3.6.3.14) activities.<sup><xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B9">9</xref></sup> The enzyme activity assays were performed at 25&#176;C with a microplate reader (&#181;Quant-MQX 200-EONC with Gen5 2.0 software connected to a computer system control; Bio-Tec Instruments, VT, USA). All the reagents were obtained from Sigma (Sigma-Aldrich, St. Louis, MO, USA).</p>
        </sec>
        <sec>
          <title>Inflammatory mediators</title>
          <p>Interferon-&#947; (IFN-&#947;) and interleukin-10 (IL-10) concentrations in LV samples were determined by ELISA according to the manufacturer&#8217;s instructions (R&amp;D Systems, Minneapolis, MN).</p>
        </sec>
        <sec>
          <title>Western blot</title>
          <p>Western blot was performed to analyze protein expression of GPx-1 (ab 22604 - Abcam Inc, Cambridge), HO-1 (ab13248 - Abcam Inc, Cambridge), total and phosphorylated NF-kB (NF-kB- sc 8008 and sc 3302- Santa Cruz Biotechnology, Inc, Europe), and sirtuin-1 (Sirt-1- sc 15404-Santa Cruz Biotechnology, Inc, Europe), in total cellular extract. To determine nuclear erythroid factor 2 (Nrf-2-sc 722-Santa Cruz Biotechnology Inc, Europe), LV samples were extracted with nuclear extraction buffer.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> Samples were separated on a 10% sodium dodecyl sulfate&#8211;polyacrylamide gel, and the proteins were transferred to a nitrocellulose membrane. The membrane was blocked with 5% nonfat dry milk and then incubated with primary and secondary antibodies. Glyceraldehyde-3-phosphate dehydrogenase GAPDH (sc 32233, Santa Cruz Biotechnology, Inc., Europe) was used for normalization of all proteins.</p>
        </sec>
        <sec>
          <title>
            <italic>Statistical analysis</italic>
          </title>
          <p>The normality of the data was verified by Kolmogorov&#8211;Smirnov statistical test. Data are presented as the mean &#177; standard deviation (SD). Variables with normal distributions were analyzed by 2-factor analysis of variance, which gives three <italic>p</italic> values: 1) factor 1, presence of MI (I); 2) factor 2, OJ intake (OJ); and 3) interaction between factors I and OJ. The 2-factor analysis of variance requires an assumption of normality. If a measurement variable does not fit a normal distribution, data transformation was performed. The Student&#8217;s unpaired <italic>t</italic> -test was used to analyze the initial echocardiogram; the &#967;<sup>2</sup>test was used to evaluate mortality, and Student&#8217;s unpaired t-test used to evaluate the infarct size in infarcted animals. Differences were considered statistically significant if <italic>p</italic> &lt;0.05. Statistical analyses were performed using SigmaPlot for Windows 12.0 (Systat Software Inc., San Jose, CA).</p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <p>The initial echocardiogram showed that animals of both infarcted groups did not present differences in the systolic and diastolic area or in the infarct size ( <xref ref-type="table" rid="t1001">Table 1</xref> of Supplementary material).</p>
        <p>
          <table-wrap id="t1001">
            <label>Table 1</label>
            <caption>
              <title>&#8211; Infarction size, final echocardiogram, and morphometric analysis.</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="13%">
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Variable</th>
                  <th>SM (n = 19)</th>
                  <th>SOJ (n = 20)</th>
                  <th>IM (n = 9)</th>
                  <th>IOJ (n = 9)</th>
                  <th>p (I)</th>
                  <th>p (OJ)</th>
                  <th>p (I&#215;OJ)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>BW (g)</td>
                  <td align="center">454&#177;47.9</td>
                  <td align="center">480&#177;56.3</td>
                  <td align="center">443&#177;66.6</td>
                  <td align="center">462&#177;25.9</td>
                  <td align="center">0.338</td>
                  <td align="center">0.135</td>
                  <td align="center">0.852</td>
                </tr>
                <tr>
                  <td>HR (bpm)</td>
                  <td align="center">290&#177;30.9</td>
                  <td align="center">296&#177;34.9</td>
                  <td align="center">268&#177;26.7</td>
                  <td align="center">324&#177;30.0<sup>aB</sup></td>
                  <td align="center">0.756</td>
                  <td align="center">0.001</td>
                  <td align="center">0.009</td>
                </tr>
                <tr>
                  <td>LA/Ao</td>
                  <td align="center">1.32&#177;0.09</td>
                  <td align="center">1.21&#177;0.09<sup>b</sup></td>
                  <td align="center">1.78&#177;0.21<sup>A</sup></td>
                  <td align="center">1.42&#177;0.18<sup>Ba</sup></td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.003</td>
                </tr>
                <tr>
                  <td>LVEDD/BW (mm/kg)</td>
                  <td align="center">15.9&#177;1.31</td>
                  <td align="center">15.0&#177;1.79</td>
                  <td align="center">22.1&#177;2.70</td>
                  <td align="center">20.2&#177;2.10</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.019</td>
                  <td align="center">0.398</td>
                </tr>
                <tr>
                  <td>LVESD/BW (mm/kg)</td>
                  <td align="center">6.67&#177;0.87</td>
                  <td align="center">6.02&#177;0.89</td>
                  <td align="center">15.1&#177;2.70</td>
                  <td align="center">12.8&#177;2.70</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.007</td>
                  <td align="center">0.556</td>
                </tr>
                <tr>
                  <td>LVMI (g/kg)</td>
                  <td align="center">1.63&#177;0.22</td>
                  <td align="center">1.56&#177;0.27</td>
                  <td align="center">2.62&#177;0.60</td>
                  <td align="center">2.36&#177;0.36</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.124</td>
                  <td align="center">0.640</td>
                </tr>
                <tr>
                  <td>FAC (%)</td>
                  <td align="center">67.3&#177;8.28</td>
                  <td align="center">67.4&#177;8.27</td>
                  <td align="center">34.5&#177;8.28</td>
                  <td align="center">36.6&#177;8.28</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.661</td>
                  <td align="center">0.707</td>
                </tr>
                <tr>
                  <td>E wave (ms)</td>
                  <td align="center">79.7&#177;11.3</td>
                  <td align="center">81.4&#177;7.16</td>
                  <td align="center">89.1&#177;10.8</td>
                  <td align="center">80.7&#177;19.2</td>
                  <td align="center">0.204</td>
                  <td align="center">0.325</td>
                  <td align="center">0.139</td>
                </tr>
                <tr>
                  <td>A wave (ms)</td>
                  <td align="center">49.9&#177;8.28</td>
                  <td align="center">52.6&#177;7.16</td>
                  <td align="center">42.5&#177;16.5</td>
                  <td align="center">62.7&#177;24.9<sup>a</sup></td>
                  <td align="center">0.730</td>
                  <td align="center">0.004</td>
                  <td align="center">0.025</td>
                </tr>
                <tr>
                  <td>S&#180; mean (cm/s)</td>
                  <td align="center">5.78&#177;0.04</td>
                  <td align="center">5.82&#177;0.31</td>
                  <td align="center">4.60&#177;0.30</td>
                  <td align="center">5.01&#177;0.3</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.028</td>
                  <td align="center">0.078</td>
                </tr>
                <tr>
                  <td>E&#180; mean (cm/s)</td>
                  <td align="center">5.62&#177;0.44</td>
                  <td align="center">5.82&#177;0.45</td>
                  <td align="center">4.23&#177;0.60</td>
                  <td align="center">4.77&#177;0.60</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.054</td>
                  <td align="center">0.357</td>
                </tr>
                <tr>
                  <td>A&#180; mean (cm/s)</td>
                  <td align="center">3.67&#177;0.44</td>
                  <td align="center">4.02&#177;0.45</td>
                  <td align="center">4.54&#177;0.90</td>
                  <td align="center">5.55&#177;1.20</td>
                  <td align="center">0.058</td>
                  <td align="center">0.058</td>
                  <td align="center">0.28</td>
                </tr>
                <tr>
                  <td>E/E&#180; ratio</td>
                  <td align="center">13.7&#177;3.49</td>
                  <td align="center">14.1&#177;1.79</td>
                  <td align="center">21.3&#177;3.30<sup>A</sup></td>
                  <td align="center">16.9&#177;2.40<sup>Ba</sup></td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.002</td>
                  <td align="center">0.003</td>
                </tr>
                <tr>
                  <td>LVW/BW (mg/g)</td>
                  <td align="center">1.85&#177;0.13</td>
                  <td align="center">1.93&#177;0.27</td>
                  <td align="center">2.13&#177;0.42</td>
                  <td align="center">2.10&#177;0.15</td>
                  <td align="center">0.005</td>
                  <td align="center">0.550</td>
                  <td align="center">0.822</td>
                </tr>
                <tr>
                  <td>RVW/BW (mg/g)</td>
                  <td align="center">0.46&#177;0.09</td>
                  <td align="center">0.43&#177;0.05</td>
                  <td align="center">0.65&#177;0.24</td>
                  <td align="center">0.59&#177;0.27</td>
                  <td align="center">&lt;0.001</td>
                  <td align="center">0.294</td>
                  <td align="center">0.776</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN1001">
                <p>
                  <italic>Data are expressed as mean &#177; standard deviation. n: numbers of animals included in each experimental group. SM: sham animals that received maltodextrin; SOJ: sham animals that received orange juice; IM: infarcted animals that received maltodextrin; IOJ: infarcted animals that received orange juice. BW: body weight; HR: heart rate; LA: left atrial diameter; Ao: aorta diameter; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVMI: left ventricular mass index (left ventricular mass/BW); FAC: fractional area change; E wave: early diastolic mitral inflow velocity; A wave: late diastolic mitral inflow velocity; S&#180; mean: mean of systolic annular mitral velocity septal and lateral; A&#180; and E&#180; mean: mean of diastolic annular mitral velocity septal and lateral (E&#180;: early and A: late); LVW: left ventricular weight; RVW: right ventricular weight. pI: p value for the effect of infarction. pOJ: <underline>p</underline> value of the effect of orange juice intake. pIxOJ: p value of interaction. Bold numbers represent statistically significant effects;<sup>a</sup>: IM&#8800;IOJ;<sup>b</sup>: SM&#8800;SOJ;<sup>A</sup>: SM&#8800;IM e<sup>B:</sup>SOJ&#8800;IOJ.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p>During the 3-month experimental period, mortality was 5.0% in the SM (1 rat died), 0% in the SOJ, 22.5% in the IM (9 rats died), and 22.5% in the IOJ group (9 rats died). When all groups were analyzed, a difference in mortality was observed between the groups (p=0.04). However, mortality was not different between the infarcted groups (p=0.836). After the period of OJ intake, euthanasia of surviving animals was performed. Then, histological analysis of the left ventricle of infarcted animals was performed to verify the infarction size ( <xref ref-type="fig" rid="f01001">Figure 1</xref> of the Supplementary material). These animals did not present a difference in infarct size (IM= 40.1&#177;7.41%; IOJ=38.1&#177;5.76%; p= 0.528). The final body weight (BW) was not different among the groups ( <xref ref-type="table" rid="t1001">Table 1</xref> ).</p>
        <sec>
          <title>Effect of MI in rat hearts</title>
          <p>MI led to adverse CR. Regarding morphological data, MI led to higher values of LV diastolic diameter/BW, LV systolic diameter/BW, left atrial diameter/aorta, LV mass index (LVMI), LV weight/BW, and right ventricular weight/BW ( <xref ref-type="table" rid="t1001">Table 1</xref> ), LV posterior wall thickness/BW, interventricular septum wall thickness/BW, and left atrial diameter/BW ( <xref ref-type="table" rid="t1001">Table 1</xref> of Supplementary material). These changes characterize the enlargement of the left cavities and LV hypertrophy. MI impaired cardiac systolic function, as shown by the lower values of fractional area change (FAC), S&#180; mean ( <xref ref-type="table" rid="t1001">Table 1</xref> ), endocardial fractional shortening, and ejection fraction ( <xref ref-type="table" rid="t2001">Table 2</xref> of Supplementary material). Cardiac diastolic function was also impaired, as shown by decreased mean E&#180; ( <xref ref-type="table" rid="t1001">Table 1</xref> ), E wave deceleration time, E&#180; lateral, and E&#180; septal ( <xref ref-type="table" rid="t2001">Table 2</xref> of Supplementary material) and increased A wave, A&#180; mean; E/E&#180; ratio ( <xref ref-type="table" rid="t1001">Table 1</xref> ), Tei index, E/A ratio, isovolumetric relaxation time adjusted by heart rate, A&#180; lateral, and A&#180; septal.</p>
          <p>
            <table-wrap id="t2001">
              <label>Table 2</label>
              <caption>
                <title>&#8211; Oxidative stress and inflammatory markers</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup width="13%">
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Variable</th>
                    <th>SM (n = 8)</th>
                    <th>SOJ (n = 8)</th>
                    <th>IM (n = 4)</th>
                    <th>IOJ (n = 4)</th>
                    <th>p (I)</th>
                    <th>p (OJ)</th>
                    <th>p (I&#215;OJ)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td>LH (nmol/g)</td>
                    <td align="center">209&#177;28.3</td>
                    <td align="center">215&#177;28.3</td>
                    <td align="center">256&#177;28.0</td>
                    <td align="center">277&#177;26.0</td>
                    <td align="center">&lt;0.001</td>
                    <td align="center">0.293</td>
                    <td align="center">0.573</td>
                  </tr>
                  <tr>
                    <td>Catalase (&#181;mol/g)</td>
                    <td align="center">64.4&#177;6.79</td>
                    <td align="center">61.8&#177;7.07</td>
                    <td align="center">55.4&#177;7.00</td>
                    <td align="center">58.1&#177;7.60</td>
                    <td align="center">0.056</td>
                    <td align="center">0.993</td>
                    <td align="center">0.404</td>
                  </tr>
                  <tr>
                    <td>SOD (nmol/mg)</td>
                    <td align="center">12.9&#177;2.83</td>
                    <td align="center">13.5&#177;2.83</td>
                    <td align="center">18.7&#177;1.80</td>
                    <td align="center">17.1&#177;1.40</td>
                    <td align="center">&lt;0.001</td>
                    <td align="center">0.639</td>
                    <td align="center">0.355</td>
                  </tr>
                  <tr>
                    <td>GSH-px activity (nmol/mg)</td>
                    <td align="center">62.5&#177;6.51</td>
                    <td align="center">50.2&#177;7.07</td>
                    <td align="center">58.0&#177;7.00</td>
                    <td align="center">45.3&#177;6.00</td>
                    <td align="center">0.134</td>
                    <td align="center">&lt;0.001</td>
                    <td align="center">0.951</td>
                  </tr>
                  <tr>
                    <td>GSH-px expression (arbitrary unit)</td>
                    <td align="center">7.56&#177;7.39</td>
                    <td align="center">7.62&#177;10.8</td>
                    <td align="center">6.63&#177;5.82</td>
                    <td align="center">6.37&#177;3.78</td>
                    <td align="center">0.600</td>
                    <td align="center">0.649</td>
                    <td align="center">0.546</td>
                  </tr>
                  <tr>
                    <td>IL-10 (pg/mg)</td>
                    <td align="center">23.9&#177;7.92</td>
                    <td align="center">39.6&#177;13.0<sup>b</sup></td>
                    <td align="center">42.0&#177;9.60<sup>A</sup></td>
                    <td align="center">34.1&#177;7.60</td>
                    <td align="center">0.135</td>
                    <td align="center">0.352</td>
                    <td align="center">0.008</td>
                  </tr>
                  <tr>
                    <td>IFN-&#947; (pg/mg)</td>
                    <td align="center">7.1&#177;2.26</td>
                    <td align="center">13.2&#177;3.96<sup>b</sup></td>
                    <td align="center">17.7&#177;6.80<sup>A</sup></td>
                    <td align="center">11.2&#177;2.00<sup>a</sup></td>
                    <td align="center">0.037</td>
                    <td align="center">0.928</td>
                    <td align="center">0.003</td>
                  </tr>
                  <tr>
                    <td>NF-&#954;B (arbitrary unit)</td>
                    <td align="center">7.03&#177;11.0</td>
                    <td align="center">4.61&#177;4.98</td>
                    <td align="center">3.40&#177;3.12</td>
                    <td align="center">6.80&#177;4.00</td>
                    <td align="center">0.942</td>
                    <td align="center">0.330</td>
                    <td align="center">0.266</td>
                  </tr>
                  <tr>
                    <td>p NF-&#954;B (arbitrary unit)</td>
                    <td align="center">5.40&#177;10.2</td>
                    <td align="center">3.18&#177;2.40</td>
                    <td align="center">3.28&#177;3.12</td>
                    <td align="center">5.22&#177;3.34</td>
                    <td align="center">0.587</td>
                    <td align="center">0.084</td>
                    <td align="center">0.980</td>
                  </tr>
                  <tr>
                    <td>Sirt 1 (arbitrary unit)</td>
                    <td align="center">1.81&#177;0.82</td>
                    <td align="center">2.34&#177;1.41</td>
                    <td align="center">2.42&#177;1.44</td>
                    <td align="center">1.65&#177;0.56</td>
                    <td align="center">0.925</td>
                    <td align="center">0.813</td>
                    <td align="center">0.203</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN2001">
                  <p>
                    <italic>Data are expressed as mean &#177; standard deviation. n: numbers of animals included in each experimental group. SM: sham animals that received maltodextrin; SOJ: sham animals that received orange juice; IM: infarcted animals that received maltodextrin; IOJ: infarcted animals that received orange juice. LH: lipid hydroperoxide; SOD: superoxide dismutase; GSH-px: glutathione peroxidase; IL-10: interleukin-10; INF-&#947;: interferon- &#947;; NF-&#954;B: nuclear factor&#8211;&#954;B total and phosphorylated (p NF-&#954;B); Sirt 1: sirtuin 1. pI: p value for the effect of infarction. pOJ: p value of orange juice intake effect. pIxOJ: p value of interaction.Bold numbers represent statistically significant effects.</italic>
                    <sup>
                      <italic>a</italic>
                    </sup>
                    <italic>: IM&#8800;IOJ;</italic>
                    <sup>
                      <italic>b</italic>
                    </sup>
                    <italic>: SM&#8800;SOJ;</italic>
                    <sup>
                      <italic>A</italic>
                    </sup>
                    <italic>: SM&#8800;IM e</italic>
                    <sup>
                      <italic>B:</italic>
                    </sup>
                    <italic>SOJ&#8800;IOJ.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </p>
          <p>MI also increased oxidative stress, as presented with higher LH and SOD activity ( <xref ref-type="table" rid="t2001">Table 2</xref> ), lower expression of HO-1 (Figure 1A), and of Nrf2 (Figure 1B). The inflammatory mediators IL-10 and INF-&#947; were higher in MI ( <xref ref-type="table" rid="t2001">Table 2</xref> ), and there was no difference in NF-&#954;B and Sirt-1 between infarcted and noninfarcted animals ( <xref ref-type="table" rid="t2001">Table 2</xref> and <xref ref-type="fig" rid="f02001">Figure 2</xref> of Supplementary material). A greater oxidation of carbohydrates than fatty acids and impaired energy metabolism were observed, as shown by higher activity of LDH and PFK and lower activity of OHADH, CS, and ATP synthase. No difference was observed for activity of pyruvate dehydrogenase ( <xref ref-type="table" rid="t3001">Table 3</xref> ).</p>
          <p>
            <fig id="f02001">
              <label>Figure 2</label>
              <caption>
                <title>&#8211; Scheme illustrating the main findings of this study.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-116-06-1127-90397-gf02-en.tif"/></fig>
          </p>
          <p>
            <table-wrap id="t3001">
              <label>Table 3</label>
              <caption>
                <title>&#8211; Enzymes involved in cardiac energy metabolism</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup width="13%">
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left">Variable</th>
                    <th>SM (n = 8)</th>
                    <th>SOJ (n = 8)</th>
                    <th>IM (n = 4)</th>
                    <th>IOJ (n = 4)</th>
                    <th>p (I)</th>
                    <th>p (OJ)</th>
                    <th>p (I&#215;OJ)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td>PFK (nmol/g)</td>
                    <td align="center">128&#177;17.0</td>
                    <td align="center">112&#177;24.6</td>
                    <td align="center">139&#177;26.0</td>
                    <td align="center">178&#177;26.0<sup>aB</sup></td>
                    <td align="center">&lt;0.001</td>
                    <td align="center">0.257</td>
                    <td align="center">0.011</td>
                  </tr>
                  <tr>
                    <td>LDH (nmol/mg)</td>
                    <td align="center">88.5&#177;18.7</td>
                    <td align="center">82.6&#177;18.1</td>
                    <td align="center">111&#177;18.6</td>
                    <td align="center">134&#177;16.</td>
                    <td align="center">&lt;0.001</td>
                    <td align="center">0.320</td>
                    <td align="center">0.092</td>
                  </tr>
                  <tr>
                    <td>PDH (nmol/g)</td>
                    <td align="center">344&#177;53.7</td>
                    <td align="center">385&#177;31.1</td>
                    <td align="center">345&#177;100</td>
                    <td align="center">341&#177;42.0</td>
                    <td align="center">0.386</td>
                    <td align="center">0.461</td>
                    <td align="center">0.376</td>
                  </tr>
                  <tr>
                    <td>OHADH (nmol/mg)</td>
                    <td align="center">33.2&#177;6.22</td>
                    <td align="center">33.9&#177;6.22</td>
                    <td align="center">23.8&#177;8.40</td>
                    <td align="center">24.5&#177;2.80</td>
                    <td align="center">0.003</td>
                    <td align="center">0.798</td>
                    <td align="center">0.992</td>
                  </tr>
                  <tr>
                    <td>CS (nmol/mg)</td>
                    <td align="center">50.0&#177;6.22</td>
                    <td align="center">49.4&#177;6.51</td>
                    <td align="center">34.5&#177;7.40</td>
                    <td align="center">40.5&#177;4.80</td>
                    <td align="center">&lt;0.001</td>
                    <td align="center">0.350</td>
                    <td align="center">0.254</td>
                  </tr>
                  <tr>
                    <td>ATP synthase (nmol/mg)</td>
                    <td align="center">21.0&#177;3.11</td>
                    <td align="center">27.8&#177;5.37</td>
                    <td align="center">11.4&#177;1.20</td>
                    <td align="center">15.9&#177;4.40</td>
                    <td align="center">&lt;0.001</td>
                    <td align="center">0.005</td>
                    <td align="center">0.532</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN3001">
                  <p>
                    <italic>Data are expressed as mean &#177; standard deviation. n: numbers of animals included in each experimental group. SM: sham animals that received maltodextrin; SOJ: sham animals that received orange juice; IM: infarcted animals that received maltodextrin; IOJ: infarcted animals that received orange juice. PFK: phosphofructokinase; LDH: lactate dehydrogenase; PDH: pyruvate dehydrogenase; OHADH: 3-hydroxyacyl coenzyme-A dehydrogenase; CS: citrate synthase; ATP: adenosine triphosphate. pI: p value for the effect of infarction. pOJ: p value of orange juice intake effect. pIxOJ: p value of interaction. Bold numbers represent statistically significant effects.<sup>a</sup>: IM&#8800;IOJ;<sup>b</sup>: SM&#8800;SOJ;<sup>A</sup>: SM&#8800;IM e<sup>B:</sup>SOJ&#8800;IOJ.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </p>
        </sec>
        <sec>
          <title>Effect of OJ intake on rat hearts</title>
          <p>OJ intake reduced the LV cavity, with lower values of LV end-diastolic diameter (LVDD) and LV end-systolic diameter (LVSD); improved systolic function, with higher values of S&#180; mean; and improved diastolic function, with lower left atrial diameter adjusted for aorta diameter ( <xref ref-type="table" rid="t1001">Table 1</xref> )<sup><xref ref-type="bibr" rid="B29">29</xref></sup> after MI. No differences were observed for other echocardiographic variables ( <xref ref-type="table" rid="t1001">Table 1</xref> ). The other function variables were not valued because of the higher heart rate<sup><xref ref-type="bibr" rid="B30">30</xref></sup> in the IOJ group (presented in Supplementary material <xref ref-type="table" rid="t2001">Table 2</xref> ).</p>
          <p>In addition, the animals that consumed OJ presented lower activity of GSH-Px ( <xref ref-type="table" rid="t2001">Table 2</xref> ). No differences were observed for LH, SOD activity, catalase activity, or GSH-Px expression ( <xref ref-type="table" rid="t2001">Table 2</xref> and <xref ref-type="fig" rid="f02001">Figure 2</xref> of the Supplementary material).</p>
          <p>Regarding the inflammatory mediators, the SOJ group showed higher IL-10 and INF-&#947; than the SM group ( <xref ref-type="table" rid="t2001">Table 2</xref> ). Also, the IOJ group had lower INF-&#947; values than the IM group ( <xref ref-type="table" rid="t2001">Table 2</xref> ). No differences were observed for NF-&#954;B or Sirt-1 between animals that consumed or did not consume OJ ( <xref ref-type="table" rid="t2001">Table 2</xref> and <xref ref-type="fig" rid="f02001">Figure 2</xref> of the Supplementary material).</p>
          <p>An improvement in the use of substrate occurred in the animals that consumed OJ. We observed higher values in PFK activity in the IOJ group compared with the IM group and higher activity of ATP synthase in animals that consumed OJ. No difference was observed in the activity of other energy metabolism enzymes between the groups ( <xref ref-type="table" rid="t3001">Table 3</xref> ).</p>
          <p>Interestingly, the animals with OJ intake had a higher expression of HO-1 (Figure 1A), although they did not present a difference in Nrf2 expression (Figure 1B).</p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>In the present study, MI induced by coronary artery ligation in rats resulted in LV hypertrophy and diastolic dysfunction, which was compatible with changes observed in chronic infarction.<sup><xref ref-type="bibr" rid="B11">11</xref></sup> Our data also showed increased oxidative stress and inflammatory markers as well as alterations in energy metabolism, with impairment of fatty acid &#946;-oxidation. These alterations characterize the CR process.<sup><xref ref-type="bibr" rid="B31">31</xref> - <xref ref-type="bibr" rid="B33">33</xref></sup> We also observe a decrease in Nrf2 and HO-1 expression. In the chronic phase of MI, the Nrf2 pathway may be diminished by abnormal expression of the Nrf2 target gene, affecting the maintenance of redox homeostasis via enzymes mediated by antioxidant response elements.<sup><xref ref-type="bibr" rid="B34">34</xref></sup> In a previous study conducted in our laboratory with the MI model, lower expression of Nrf2 and HO-1 was observed.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> These findings suggest either a lower expression or greater catabolism of the Nrf2 protein, thus leading to the lower synthesis of HO-1.</p>
        <p>In the present study, OJ intake resulted in attenuation of CR in infarcted animals. This attenuation can be observed in the decrease of LV cavity (LVDD and LVSD) and in the improvement of systolic function, characterized by the increase in the S&#180; mean,<sup><xref ref-type="bibr" rid="B35">35</xref></sup> and diastolic function (lower left atrial diameter). In the study by Yu et al.,<sup><xref ref-type="bibr" rid="B36">36</xref></sup> infarcted rats, by left coronary ligation, treated with hesperidin for four weeks had lower LVDD and LVSD and improved systolic function than infarcted animals. These data are similar to ours and may show the effect of hesperidin of OJ on the CR process. In other study, another phenolic compound, hesperetin, also had an effect on the heart. In pressure-overload model, Deng et al.<sup><xref ref-type="bibr" rid="B37">37</xref></sup> found lower values of LVDD and LVSD at eight weeks of hesperetin administration.</p>
        <p>MI leads to an imbalance between the production of ROS and antioxidant defenses, leading to oxidative stress. After ischemia, some ROSs damage cell membranes, initiating the process of lipid peroxidation.<sup><xref ref-type="bibr" rid="B38">38</xref></sup> For example, Bagatini et al.<sup><xref ref-type="bibr" rid="B39">39</xref></sup> described an increase in lipid peroxidation in patients with MI. Our data also show a higher concentrations of lipid hydroperoxides in infarcted animals compared to non-infarcted animals. The SOD enzyme is the organism&#8217;s first defense against ROS.<sup><xref ref-type="bibr" rid="B40">40</xref></sup> Our data show that infarcted animals compared to non-infarcted animals showed greater activity of the SOD enzyme, as previously described.<sup><xref ref-type="bibr" rid="B3">3</xref> , <xref ref-type="bibr" rid="B25">25</xref></sup> Regarding OJ intake, we observed that the animals that consumed OJ presented lower GSH-Px activity. A similar result was shown by Selvaraj and Pugalendi<sup><xref ref-type="bibr" rid="B41">41</xref></sup> in myocardial ischemia model induced by isoproterenol: rats that received hesperidin presented lower activity of the antioxidant enzymes, among them GSH-Px.<sup><xref ref-type="bibr" rid="B41">41</xref></sup></p>
        <p>In relation to energy metabolism, the heart, like other organs, can adapt and use the best energy substrate in each situation. PFK acts in glycolysis regulation, and catalyzes the phosphorylation of glucose in fructose-6-phosphate and subsequently in fructose 1,6-bisphosphate.<sup><xref ref-type="bibr" rid="B42">42</xref></sup> PFK is activated when ATP concentrations become low and is inhibited when cells have sufficient supply of ATP and other substrates such as fatty acids.<sup><xref ref-type="bibr" rid="B42">42</xref></sup> Our data showed higher values of PFK in infarcted animals with OJ intake. These data show that increased PFK activity may lead to regulation of the glycolytic pathway, by providing more substrate for energy production. Another important finding that indicates a greater use of substrate is the higher ATP synthase activity in the animals that received OJ.</p>
        <p>In addition to oxidative stress and metabolic changes, we found that the infarcted animals that received OJ presented lower values of IFN-&#947;. Since a chronic phase of inflammation is related to an increased production of IFN-&#947;,<sup><xref ref-type="bibr" rid="B43">43</xref></sup> our findings suggest more advanced phase towards the resolution of the inflammatory process. An interesting result is that sham animals who consumed OJ demonstrated an immunomodulatory effect, as shown by higher values of IL-10 and INF-&#947;. Similar to our findings in animals in the sham group, which had no cardiac injury, studies in healthy, middle-aged humans showed that OJ altered leukocyte gene expression to an anti-inflammatory and anti-atherogenic profile<sup><xref ref-type="bibr" rid="B44">44</xref></sup> and provided an early protection of mononuclear blood cell against oxidative DNA damage.<sup><xref ref-type="bibr" rid="B45">45</xref></sup> In addition, OJ intake with the high-carbohydrate meal prevented meal-induced oxidative and inflammatory stress.<sup><xref ref-type="bibr" rid="B46">46</xref></sup></p>
        <p>Another intriguing finding in our study was the higher values of HO-1 in animals that consumed OJ. Lin et al.<sup><xref ref-type="bibr" rid="B47">47</xref></sup> in 2005 also showed that hesperetin induced protein expression of HO-1.<sup><xref ref-type="bibr" rid="B47">47</xref></sup> The HO-1 enzyme plays important role in cell homeostasis because of its catabolic action on the heme group of hemoproteins, generating by-products such as iron, biliverdin, and carbon monoxide. Through these by-products, HO-1 exerts anti-inflammatory, antioxidant, and antiapoptotic action.<sup><xref ref-type="bibr" rid="B48">48</xref> , <xref ref-type="bibr" rid="B49">49</xref></sup> In addition to this classical function, HO-1 participates in cell signaling as amplifier of inductors (heme, oxidants, cytokines, hemodynamic forces, growth factors, hypoxia, and hormones) of transcription factors.<sup><xref ref-type="bibr" rid="B48">48</xref></sup></p>
        <p>Wang et al.<sup><xref ref-type="bibr" rid="B50">50</xref></sup> showed that HO-1 is important for heart homeostasis by protecting it from ischemia and reperfusion-induced lesions and oxidative damage.<sup><xref ref-type="bibr" rid="B50">50</xref></sup> In another study, hemin administration in infarcted mice induced HO-1 activation, which caused a change in infarct macrophages toward a M2 anti-inflammatory phenotype, reduction of infarct scar expansion, and improvement of cardiac function.<sup><xref ref-type="bibr" rid="B51">51</xref></sup> Thus, increased HO-1 may also play an important role in CR attenuation by OJ ( <xref ref-type="fig" rid="f02001">Figure 2</xref> ). In addition, this increase was independent of the Nrf2 pathway, since OJ did not lead to alterations in the expression of this protein. Similar to our findings, Wang et al.<sup><xref ref-type="bibr" rid="B52">52</xref></sup> found that isoliquiritin and isoliquiritigenin, flavonoids derived from liquorice, induced HO-1 expression independent of Nrf2 expression.<sup><xref ref-type="bibr" rid="B52">52</xref></sup> The HO-1 expression can be induced by different pathway and may vary according to the model and treatment used.<sup><xref ref-type="bibr" rid="B47">47</xref></sup></p>
        <sec>
          <title>Limitations</title>
          <p>The OJ used in the study was a commercial, ready-to-eat, pasteurized juice, free of preservatives and sugar. The choice of ready juice was to ensure its standardization. However, the use of other types of juices, made with other types of oranges, could possibly show different responses.</p>
        </sec>
      </sec>
      <sec sec-type="conclusions">
        <title>Conclusion</title>
        <p>OJ attenuated CR after MI, with decreased LV diameter as well as improvement in systolic and diastolic function; HO-1 may play an important role in this process.</p>
      </sec>
    </body>
    <back>
      <ack>
        <title>Acknowledgments</title>
        <p>This work was supported by grant from Coordination for the Improvement of Higher Education Personnel (CAPES).</p>
      </ack>
      <fn-group>
        <fn fn-type="other">
          <p>Study Association</p>
          <p>This article is part of the thesis of master submitted by Bruna Camargo de Oliveira, from Universidade Estadual Paulista J&#250;lio de Mesquita Filho Campus de Botucatu - Faculdade de Medicina.</p>
        </fn>
      </fn-group>
      <fn-group>
        <fn fn-type="supported-by">
          <p><bold>Sources of Funding</bold>: This study was partially funded by CAPES.</p>
        </fn>
      </fn-group>
      <app-group>
        <app id="app1_en">
          <title>* Supplemental Materials</title>
          <p>For additional information, please click here.</p>
          <supplementary-material id="suppl1_en" mime-subtype="pdf" mimetype="application" xlink:href=""/>
        </app>
      </app-group>
    </back>
  </sub-article>
</article>
